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ABSTRACT 
In the field of drug discovery and disease diagnostics, protein microarrays have 
generated much enthusiasm for their high-throughput monitoring of biomarkers; 
however, this technology has yet to translate from research laboratories to 
commercialization. The hindrance is the considerable uncertainty and skepticism 
regarding data obtained. The disparity in results from different laboratories performing 
identical tests is attributed to a lack of assay quality control. Unlike DNA microarrays, 
protein microarrays have a higher level of bioreceptor immobilization variability and 
non-specific binding because of the more complex molecular structure and broader 
physiochemical properties. Traditional assay detection modalities, such as fluorescence 
microscopy and surface plasmon resonance, are unable to overcome both of these sources 
of variation. 
This dissertation describes the hardware and software design and biological validation 
of three complementary platforms that overcome bioreceptor variability and non-specific 
binding for diagnostics. In order to quantify the bioreceptor quality, a label-free, non-
destructive, low cost, and high-throughput interferometric sensor has been developed as a 
quality control tool. The quality control tool was combined with a wide-field 
VI 
fluorescence imaging system to improve fluorescence experimental repeatability. Lastly, 
a novel high-throughput and label-free platform for quality control and specific protein 
microarray detection is described. This platform overcomes the additional complexities 
and time required with labeled assays by discriminating between specific and non-
specific detection by including sizing of individual binding events. 
Protein microarrays may one day emerge as routine clinical laboratory tests; however, 
it is important that the proper quality control procedures are in place to minimize 
erroneous results. These platforms provide reliable and repeatable protein microarray 
measurements for new advancements in disease diagnostics with the potential for drug 
discovery. 
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Chapter 1 
INTRODUCTION & BACKGROUND 
This dissertation describes the design and characterization of three instruments (the 
interferometric reflectance imaging sensor (IRIS), the calibrated fluorescence 
enhancement (CaFE), and the single particle interferometric reflectance imaging sensor 
(SP-IRIS)) for high-throughput, sensitive, and repeatable protein microarray assay 
detection and quality control. These platforms are compact, low-cost, and non-destructive 
quality control tools [1], [2]. Moreover, the platforms discussed reduce operational 
complexity and user-variability through automation. The user-friendly nature of these 
tools has facilitated the distribution to our collaborative laboratories at the Istituto di 
Chimica del Riconoscimento Molecolare, (Milano, Italy) for assay development and the 
Microbiology Dept., (Boston University, Boston, MA) for viral hemorrhagic fever and 
allergy diagnostics [3 ]-[ 6]. 
Chapter 1 will give a general description of biosensors and a detailed discussion on 
the current and emerging technologies in multiplexed protein detection. In Chapter 2, the 
underlying principles of IRIS are described along with design considerations and the 
· development of the 211d generation IRIS instrument. The design of the two CaFE chips 
and the CaFE instrument are discussed in Chapter 3. Chapter 4 discusses the rationale for 
SP-IRIS, the theory behind nanoparticle sizing for specific detection, and the 
development of an automated, standalone prototype. Finally, Chapter 5 contains 
comments for further research and conclusive remarks for further developing these 
technologies. 
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1.1 Introduction 
The complex binding relationships of biological molecules drives the operation of 
living organisms. System irregularities, such as disease symptoms, occur when the 
balance of the molecules is interrupted through the introduction of foreign particles or 
perturbation in functionality or concentration of biomarkers. Although several diseases 
are detectable through profiling DNA biomarkers, DNA does not directly indicate 
cellular activity. Measuring the relative or absolute protein concentration offers a more 
complete understanding of the disease pathogenesis for diagnosis and treatment [7] , [8]. 
Although many microarray detection platforms have been demonstrated for massively 
multiplexed (tens of thousands of ligands) and high sensitivity measurements 
(picogram/mL to nanogram/mL concentrations) in pure solutions spiked with protein 
biomarkers, their practicality in clinical protein samples like whole blood or sputum has 
been hindered because of low repeatability and high noise floors [9], [10]. The 
repeatability is affected by the physicochemical variation between proteins that induces 
fluctuation in the immobilized probe density [11], [12]. A high noise floor arises from 
false signal due to non-specific binding in clinical samples, where other biomolecules are 
present in concentrations a billion times greater than the target biomarkers [ 13]. Current 
detection methods are able to overcome probe immobilization variation or non-specific 
binding but not both. 
To address probe immobilization variability, the IRIS platform has been developed 
using optical interferometry and spectroscopy to quantify mass accumulation on a silicon 
dioxide on silicon (Si02/Si) chip. The 1st generation IRIS design provided rapid label-free 
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measurements of thousands of proteins simultaneously with an intrinsic mass detection 
limit of 4 pg/mm2 [14]. Refining this design, the 2nd generation platform improves the 
ease-of-use, the footprint, the robustness, and the cost ($30K to $1 OK) without sacrificing 
throughput or sensitivity [1]. The new IRIS design implements light~emitting diodes 
(LEDs) as the illumination source, a new Si02/Si design to account for the LEDs ' 
spectral range, a novel IRIS analytical model for the LEDs ' line width, and an on-chip 
intensity monitoring region to eliminate the need for an external photodetector (PD) [15]. 
The CaFE platform integrates IRIS to quantify probe immobilization with wide-field 
fluorescence imaging for discrimination between specific and non-specific detection. 
This novel microarray technique has been shown, using separate IRIS and fluorescence 
instruments, to correct for inter-experimental error from disparity in probe density [2]. 
For this technique, two Si02/Si chips have been designed: 1) a chip with two Si02 
thicknesses optimized for fluorescence enhancement and IRIS measurements for on-chip 
calibration (ONC) and 2) a single Si02 design for same spot fluorescence and IRIS 
measurements at reduced performance for co-located calibration (CLC) [2]. The ONC 
chip design calibrates the fluorescence signal with .the immobilization density of nearby 
probes. This design addresses inter-chip variation. For further calibration accuracy, the 
CLC chip design can be used for same spot calibration to account for inter- and intra-
probe variation. Lastly, an integrated IRIS and wide-field fluorescence platform has been 
designed for all-inclusive CaFE measurements [16]. The optical path design has been 
designed for sensitive fluorescence detection, a novel IRIS angular spectrum 
representation (ASR) analytical model has been developed for high numerical aperture 
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(NA) IRIS imaging, and the platform has shown equivalent performance to the separate 
IRIS and fluorescence readers. 
The final platform, SP-IRIS, overcomes the drawbacks of labeling (e.g. labels can 
affect protein functionality [17], labeled assays require more time and reagents, and the 
labeled reagents must be stored in a dark, refrigerated environment) with a label-free 
single nanoparticle method for non-specific binding filtering. Coupling this platform with 
IRIS provides a completely label-free approach to quantifying probe immobilization and 
specific detection. The SP-IRIS technique detects single nanoparticles on an 
interferometric surface using a CCD camera. By analyzing the strength of individual 
nanoparticles, the nanoparticle size can be determined for non-specific size filtering. The 
drawback to SP-IRIS is the nanoparticle signal is tightly confined in the focusing axis. In 
order to remove user focusing error, a standalone, portable, and automated SP-IRIS 
platform has been designed. A custom graphical user interface (GUI) synchronizes the 
stage, camera, and LED control for automated data acquisition and processing. With this 
software in place, the user interaction is confined to loading the chip, defining the 
microarray geometry, and clicking run. 
1.2 Biological Sensors 
Known as molecular diagnostics, the · observation of events on a molecular level has 
opened avenues for new and more effective medical treatments [18]. In order to detect 
and quantify molecular interactions, scientists and engineers have developed biosensors 
for numerous applications. At a basic level, biosensors consist of a bioreceptor and a 
transduction device. 
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Bioreceptors are molecules, such as proteins, enzymes, antibodies, and nucleic acids, 
capable of recognizing other molecules through specific interactions. These molecules 
are designed to interact with a specific target molecule, similar to a lock and key. For 
example, our bodies operate on a series of metabolic processes. In order to fuel our 
bodies, we eat food. This food is broken down into small molecules through steps called 
catabolism. The anabolism process then uses these small molecules to make proteins and 
nucleic acids for our body. These reactions are able to occur because of enzymes, a tYPe 
ofbioreceptor. Biosensors exploit the recognition behavior ofbioreceptors to specifically 
identify target molecules. 
Once the bioreceptor captures the target molecules, the binding event must be 
detected. The detection method depends on the transduction type. A transduction device 
measures the physical or chemical change due to target-receptor binding event. As 
illustrated in Figure 1.1, the transduction method can be mechanical, electrical, or optical 
in nature. 
Bioreceptors 
Nucleic Acids 
Cells 
Proteins 
Plasma Antibodies 
Enzymes 
Signal Transduction 
Interferometry 
Conductance 
Refractive Index 
Fluorescence 
Absoprtion 
Mass 
Figure 1.1: Biosensor schematic. The bioreceptors recognize their specific target molecule. When the target 
is present, they bind to the bioreceptors producing a physical or chemical change which is changed into a 
measurable signal. 
Biosensors are separated into several general categories based on (1) if the 
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bioreceptors must be affixed to a surface or are floating in-solution, (2) whether the target 
molecules are detected directly (label-free) or through secondary molecules (labeled), and 
(3) the transduction method for detection. This research will focus on detection 
modalities that take advantage of fixing the bioreceptors to a surface for multiplexed 
applications. 
1.3 Detection Formats 
Today's biosensors have progressed in prevalence as well as sophistication and 
complexity. According to a market study released by GlobalData, the blood glucose 
monitoring device market in 2010 was valued at $8.9B world-wide with a compound 
annual growth rate of 5.2% since 2003 [ 19]. Although the USA has 40% of this market, 
much of the growth going forward will stem from expanding to emerging markets who 
cannot afford the current technology [20]. Therefore, not only do emerging medical 
technologies need to continue to improve performance, but costs and ease-of-use must 
also be considered for the emerging markets. 
1.3.1 Enzyme-Linked Immunosorbent Assay 
Enzyme-linked immunosorbent assays (ELISA) are the most dominant format for 
high-throughput, singleplex assays used today. These assays detect antibodies or antigens 
by non-specifically immobilizing the patient sample inside a well of a microtiter plate 
with 96-, 384-, or 1536-wells via adsorption or specifically using a bioreceptor on the 
surface. (A 96-well plate is shown in Figure 1.2a.) After the target molecule is captured, a 
secondary bioreceptor is added to each well to "sandwich" the target. Finally, a general 
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bioreceptor with a linked enzyme is attached. The enzyme reacts with a chromogenic 
substrate1 to induce a color change in the chromogenic substrate for detection. Figure 
1.2b shows a schematic of this process. 
(1) (2) (3) (4) (5) 
•-' .- substrate 
~ ;_ t A Tagged 
' 
Receptor 
y A Secondary 
Receptor 
~ Target Molecule y Probe Rece tor (a) (b) 
Figure 1.2: Process flow of an ELISA assay. (a) Schematic of a 96-well microtiter plate. Each well runs 
singleplex (I target/well) detection. The multiple-well configuration enables a higher throughput and 
multiplexing. (b) In each well, the probes are adhered to the detection surface for specific capture of the 
target (step 1). Step 2 shows the target molecule is captured by the probe bioreceptor. In step 3, a secondary 
bioreceptor is bound to the target molecule to act as an adapter between the target molecule and the 
detection bioreceptor. Step 4 is the attachment of a tagged bioreceptor to the secondary bioreceptor. Step 5 
shows the enzyme interacting with the substrate to induce a color change in the substrate for detection. Step 
1 is skipped for protocols that non-specifically adsorb all molecules to the surface. 
At first glance, the use of a secondary bioreceptor and an enzyme-linked bioreceptor 
may seem redundant. If the indicator molecule is bound directly to the secondary 
bioreceptor instead of a tertiary bioreceptor the number of steps, the amount of reagents, 
and the assay time would be reduced. However, there are thousands of biomarkers 
detected using ELISAs and each biomarker has a corresponding probe receptor and 
secondary bioreceptor. The task of chemically linking an enzyme to each secondary 
bioreceptor while maintaining functionality is complicated and laborious. Instead, a 
tertiary bioreceptor, which is designed to recognize multiple secondary bioreceptors, is 
linked to the enzyme. 
1 Molecules which undergoes a color change in the presence of an enzyme 
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1.3.2 Microarray-based Biosensors 
The progressive demand for high-throughput and multiplexed detection of biomarkers 
has sped up the development of a large variety ofbiosensors [8]. A particularly promising 
high-throughput and multiplexed biosensor format is known as microarrays. Introduced . 
in the early 1980s [21], [22] , microarrays have grown in popularity by providing 
multiple, parallel protein and nucleic acid measurements with the same sample volume. 
Similar to ELISAs, microarrays can employ primary, secondary, and tertiary bioreceptors 
and a solid surface to bind and recognize target molecules. Unlike ELISA, microarrays 
do not physically separate the bioreceptors in wells, they are not limited to antigens and 
antibodies, and they are not limited to enzymatic reactions for detection. The probes are 
adhered to a solid surface (usually a glass slide) in a 2D grid (typically 100 J.lm diameter 
bioreceptor spots with a 200 J.lm center-to-center pitch), see Figure 1.3. This 
configuration allows a single sample volume to be tested for tens of thousands of target 
molecules concurrently. 
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Probe 2 
t 
Figure 1.3: Illustrative sketch of a microarray. Each disk represents a cluster of probes adhered to the 
surface. The multiple colors mimic the use of different bioreceptors to specifically capture target molecules 
1, 2, and 3. The co-poly(DMA-NAS-MAPS) surface chemistry used in our experiments has shown 
bioreceptor densities of about 2x10 11 molecules/mm2 [23], [24]. The exact bioreceptor density can be 
measured with IRIS. 
1.4 Current State of Biosensors 
Molecular biosensors have been designed to measure electrical [25], [26], mechanical 
[9], [27], and optical [28]-[32] fluctuations. Since the 1980s, numerous biosensors have 
been developed and characterized in these fields, shown in Figure 1.4 and Figure 1.5. 
These biosensors can be broken into two main groups: a) labeled detection and b) label-
free detection. Understanding the strength of each approach is essential to developing 
molecular diagnostics. 
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Figure 1.4: Publication frequency for each general biosensor type. Reprinted from [27]. 
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Figure 1.5: Publication frequency of label-free and labeled biosensors. Data extracted from Web of 
Knowledge on Oct. 22, 2013 . 
1.4.1 Labeled Versus Label-Free Detection 
Biosensors of every variety have been developed for labeled and label-free detection. 
Whether electrical, mechanical, or optical in nature, the biosensor is reading a chemical 
or physical signal in the local environment. The transduction signal can come from either 
the target molecule directly (label-free) or an indicator molecule (labeled). 
Labeled microarrays are the first clinically adopted biosensors. These microarrays 
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follow the same procedure as an ELISA. The key advantage of this approach is signal 
specificity. Unless the secondary bioreceptor binds to the target molecule and then the 
tertiary bioreceptor binds to the secondary bioreceptor, ~ signal will not be generated. 
The redundancy lessens the chance of signal generation from non-specific binding 
(unintended attachment of non-target molecules). Consequently, the drawback to this 
added specificity is assay complexity (bioreceptors must be selected to prevent crosstalk, 
especially when multiplexing) and assay time (multiple incubation steps). In most tests, 
each incubation step requires 1 hour, but this time depends on the binding affmity, 
molecule concentration, molecular diffusion rate, and detection sensitivity. Therefore, in 
general, labeled detection is not applicable to time critical situations or where assay 
complexity is an issue. 
Label-free detection is a simpler assay that does not require additional incubation 
steps to label the target molecules. Observation of target binding is directly measured 
through an electrical, mechanical, or optical material property. In buffer solutions, label-
free techniques have shown competitive sensitivities in a reduced number of steps by 
eliminating the secondary and tertiary bioreceptors [14]; however, removing the 
additional binding steps sacrifices selectivity [33]. The discrimination between specific 
and non-specific binding is no longer improved by the binding affinities of the secondary 
and tertiary bioreceptors. This lack of specificity becomes apparent in a complex 
solution, such as serum or whole blood, where non-specific binding, not the detection 
technique, limits the sensitivity [34], [35]. To compete with labeled detection in 
clinically-relevant solutions, label-free detection techniques must either implement 
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complex sample purification procedures [36] or detect and discriminate binding label-
free, discussed in Chapter 4. 
1.4.2 Transduction Types 
Electrical Biosensors. Electrical biosensors operate on the concept of measuring 
change in conductance to detect molecular binding [25] , [26] , [37]. The two common 
types of readout modalities are label-free with field-effect transistors (FETs) for charged 
target molecules [26], [38] or labeled detection using interdigitated electrodes - an 
addressable comb-like electrode structure- and an enzymatic reaction [25], [37]. In both 
cases, a sensing region is functionalized with the primary bioreceptor, as shown in Figure 
1.6. When the target molecule binds to the sensing region, the local conductance is 
changed directly or through an enzymatic reaction with a substrate that produces a 
chemical product. 
Functionalized 
e Target 
protein 
1. Initial unbound stage 
+ Binding of 
target protein 
2. Final bound stage 
lkt:= 
u T. 1me 
.. . 
Figure 1.6: Diagram of a basic electrical biosensor. Binding of the target protein induces a change in the 
local conductance directly or through an enzymatic reaction. Reprinted from [39]. 
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Nanowire sensors have shown real-time measurement of femtomolar to nanomolar 
protein concentrations using carbon or silicon nanowires [8]. For example, traditional 
FET configurations have shown the capability of Dengue fever serotyping with peptide 
nucleic acids on silicon nanowires [ 40]. Silicon nanowires have also been applied to 
DNA and protein detection with attomolar to nanomolar sensitivity (41]. Sarkar et al. 
suggested a new FET scheme, termed impact-ionization FET, can increase sensitivity an 
additional four orders of magnitude [26]. 
Scaling-up of fabrication tohigh-volume manufacturing is the major limitation ofthis 
technology. Current top-down and bottom-up nanowire fabrication methods require the 
nanowires and electrodes to be fabricated separately then assembled. This fabrication 
process has low device yield and is incompatible with large-scale semiconductor device 
processes [36], [ 42], [ 43]. Recently, Shalev et al. addressed the manufacturing issue with 
the introduction of an electrostatically-formed nanowire. Their approach to nanowire 
sensing demonstrated a 10 pg/mL (~340 fM) detection limit of cardiac troponin on a 
sensor fabricated using standard complementary metal-oxide semiconductor (CMOS) 
practices, including thermal diffusion doping, low-pressure chemical vapor deposition, 
plasma-enhanced chemical vapor deposition, and sputtering [ 44]. 
Nanowire sensors have shown great promise as real-time, portable measurement tools 
for the label-free detection of charged molecules. As innovations in the fabrication 
procedures and sensor design continue, the non-standard fabrication processes that 
decrease device yield and performance can be replaced, enabling high-density arrays. The 
sensitivity of nanowires, however, shows the same limitation as many other label-free 
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technologies- the specificity of detection relies solely on the probe affinity to the target 
molecule. For clinical applications, sample purification steps will be required to minimize 
non-specific binding for practical use of nanowires. 
Nano-mechanical Biosensors. With advancements in nanofabrication techniques, 
mechanical transducers with deformable features are used for mass sensing. Nan6-
mechanical type biosensors rely on two types of changes when molecules bind to 
immobilized bioreceptors: physical displacement and resonance frequency shifts. Nano-
mechanical systems function with nanometer-sized mechanically resonant structures, like 
graphene sheets, free-standing cantilevers, doubly clamped beams, or membranes, [27]. 
In the case of nanocantilever biosensors, the stress-induced on the surface from 
binding causes a bending of the cantilever arm and shifts the resonance frequency 
proportionally [45], as shown in Figure 1.7. This approach to mass sensing has 
demonstrated 1 ng/mL detection of cyanovirin-N, a carbohydrate-protein [ 46] and single 
cell growth with femtogram sensitivity [ 47]. Although nano-mechanical biosensors are 
theorized to detect zeptogram mass changes - the mass of a single protein - with double-
wall carbon nanowires [ 48] or even yoctogram mass changes with graphene sheets [ 49], 
experimentally there has not been a demonstration beyond 1 ng/mL in biological 
experiments. As noted by Arlett et al., the detector performance of these sensors 1s 
limited in biological samples by non-specific binding effects and not the intrinsic 
biosensor performance [13]. 
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Figure 1.7: Operation modes of nano-mechanical biosensors. As biomolecules bind to the cantilever arm, 
the stress applied to the surface induces a bending. (a) Static mode measures the arm-displacement to infer 
the amount of stress applied, which correlates to mass. (b) Dynamic mode monitors the resonant frequency 
and the corresponding shifts as mass attaches. Reprinted from [27] 
Optical Biosensors. As shown in Figure 1.4, research on optical transduction methods 
exceeds all other techniques. The popularity of optical devices comes from the diversity 
of properties available for detection. Fluorescence sensors [50], high-Q optical resonators 
[51], [52] , photonic crystal sensors [53], [54], and plasmonic sensors [31], [55] are just a 
few of the optical methods employed in biological experiments. 
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Figure 1.8: Types of optical biosensors. I. Fluorescence detection sensitivity is improved over (a) ELISA 
and (b) microanays by (c) co-localized spotting of capture and detection antibodies to minimize cross-
reactivity. Reprinted from [50]. II. Micro-toroid resonators are used to directly detect single viral particles 
binding to the cavity. Reprinted from [52] . m. Photonic crystal structures have been used to amplify the 
fluorescence signal and quantify biomass accumulation. Reprinted from [53], [54]. V. Surface plasmon 
resonance is used to directly quantify adsorption on a gold surface. Reprinted from [31]. 
Fluorescence assays are the industry standard for clinical DNA microarrays [56] , 
[57]. This detection method is a labeled technology that relies on a secondary bioreceptor 
linked to a fluorophore to achieve a high sensitivity and selectivity. Fluorophores are 
chemical compounds that absorb photons andre-emit lower energy photons. The Stokes 
shift2 between the absorption and emission photons enables spectral filtering of non-
signal wavelengths for zeroing the background. Despite spectral filtering, the background 
is not truly eliminated. Background signal is still detected from fluorophores non-
2 Spectral shift between the absorbed photon and emitted photon 
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specifically bound and autofluorescent molecules3. In order to increase the fidelity of 
measurements, research has concentrated on enhancing sensitivity through time-gate 
detection [58], total internal reflection fluorescence [59], Forster resonance energy 
transfer [60], incorporating interferometric surfaces for a higher photon collection 
efficiency [ 61] , incorporating photonic crystal structures for a higher photon emission 
and collection efficiency [28], [53], and/or physically separating the fluorophores to 
prevent cross-talk in multiplexed conditions [50] . 
Although many techniques have been developed to enhance fluorescence detection, 
fluorescence imaging is not easily applicable to multiplexed protein assays. As mentioned 
in Section 1.3.1 , labeled assays are a multi-stage process with multiple bioreceptors. For 
each target protein in the multiplexed assay, the primary and secondary bioreceptors must 
be selected to prevent cross-reactivity. The direct binding of the secondary or tertiary 
bioreceptors to the primary bioreceptors will result in false signals. Also, additional 
complexity is introduced in labeling the bioreceptors with a fluorophore without altering 
the molecular functionality [17] . As an alternative, research has progressed on the 
development of multiplexed protein biosensors that do not require labeling of the 
bioreceptor. 
Label-free detection modalities directly measure the target molecule binding to the 
probes. Previously, the label-free detection methods were discussed using local 
conductance shifts (nanowire biosensors), and mass changes (nanocantilever biosensors). 
In optical biosensors, the transduction method is in reflection from thin-film interference 
3 Materials that naturally emit photons when illuminated 
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[14], [28], [62], [63], local refractive index changes on resonant structures (i.e. cavities, 
toroid, and spheres) [29], [52], [64], [65], and local refractive index changes in surface 
plasmon resonance [31], [32]. These sensors compared to other label-free technologies 
have shown competitive sensitivities (e.g. an intrinsic sensitivity of a single particle [66] 
and femtomolar detection of BSA [ 64]) in both single-point and imaging modalities, a 
higher level of throughput (1000s of measurements simultaneously) [14], multiplexing 
capabilities [28], and potential for specific and non-specific discrimination [67]. 
In conclusion, the current state-of-the-art optical biosensors are divided between 
labeled and label-free detection modalities. Whether mechanical, electrical, or optical, 
these techniques have not achieved their intrinsic detection limit. The limiting noise for 
these biosensors is either non-specific binding or probe immobilization density. Labeled 
detection is able to overcome non-specific binding with additional bioreceptors and 
labeling procedures; however, since a measurable signal is not generated until the label is 
present no information is provided about the probe immobilization density. Label-free 
methods are able to simplify the assay by forgoing any additional bioreceptors and 
incubation steps, but at the cost of specificity. This dissertation presents multiple 
approaches to surpass the limitation of labeled and label-free techniques through a hybrid 
label-free/label detection method and a novel label-free method capable of discriminating 
between specific and non-specific binding with nanoparticle sizing. 
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Chapter 2 
PRINCIPLES OF THE INTERFEROMETRIC REFLECTANCE IMAGING SENSOR 
The incorporation of protein microarrays in clinical diagnostics has been limited by a 
lack of accurate and precise biosensors for clinical samples and quality control tools. The 
IRIS platform has been designed to provide rapid, multiplexed, and sensitive probe and 
biomarker quantification in an easy-to-use and low-cost system. The drawbacks of other 
detection technologies is their intricate design of sensors and instrumentation that 
prevents direct translation to commercialization [68] , [69]. The IRIS technique has been 
developed with practically of commercial and clinical scalability in mind. This chapter 
will discuss the underlying principles of IRIS, layout considerations for an IRIS platform, 
the 1st and 2nd generation designs, and validation procedures. 
2.1 Basic IRIS Principles 
IRIS is a spectroscopic imaging technique for measuring biomass accumulation. 
Utilizing optical interference from a Si02/Si chip, this technique is able to calculate the 
optical path difference induced by the Si02 layer. By imaging the spectral response of 
select wavelengths, minute amounts of mass binding to the surface can be quantified in a 
high-throughput format. 
The reflection and transmission of light at a single dielectric interface were first 
described by Augustin-Jean Fresnel in 1827. The Fresnel equations explain the behavior 
of transverse electric (TE) waves, s-polarized, and transverse magnetic (TM) waves, p-
polarized, incident to a planar dielectric interface. The ratio of the incident and reflected 
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fields, called the Fresnel coefficients, rs and rP , shown in Equations 2.1 and 2.2, are 
derived by imposing continuity at the interface [70]. 
(2.1 ) 
(2.2) 
(2.3) 
R s (A, B;) =I rs (A, B;) 12 • (2.4) 
Where B; and 81 are the incident and transmitted angles, n1 and n2 are the indices of 
refraction of the two materials, and Rs and RP are the total reflected intensities. For 
unpolarized light, the total reflected intensity is an average of the polarizations, 
(2.5) 
For the special case of near-normal incident, the Fresnel coefficients can be further 
simplified using a small-angle approximation, called the paraxial approximation. As seen 
in Equation 2.6 and 2.7, applying this approximation to the Fresnel equations, 
sin B; ;:::; B; ;:::; 0 , removes the polarization-dependent behavior of the reflection. 
(2.6) 
(2.7) 
In the case of a Si02/Si chip, the reflection model includes the optical resonance from 
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the Si02 cavity. As illustrated in Figure 2.1, the incident light to the Air-Si02-Si stack 
contains two main reflections, the reflection from the Air-Si02 interface and the 
aggregate reflection from the Si02/Si interface. These two reflections interfere producing 
the measured far-field ·signal. Note the light that is transmitted into the Si layer is not 
modeled as it will be absorbed. 
R 
Si 
Figure 2.1 : Reflection model of an Air-SiOrSi configuration 
The close-form equation of the 3-layer chip reflection, shown in Equation 2.8, is 
derived using geometric optics [70]. This model has the assumptions of near-normal 
incidence and a narrow linewidth illumination source. 
(2.8) 
(2.9) 
(2.10) 
(2.11) 
Where r1 and r2 are the Fresnel reflection coefficients of the Air-Si02 interface and 
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Si02-Si interface, d is the thickness of Si02 layer, and kz is the wavenumber in Si02 
layer perpendicular to the interface. 
IRIS utilizes the Air-SiOrSi analytical model and acquired spectral data to extract the 
Si02 layer thickness and the surface bound density of adsorbed biomass. In the analytical 
model, all the variables are well defined except the Si02 thickness, d . Using an error 
minimization algorithm, such as the Levenberg-Marquardt algorithm, the Si02 layer 
thickness and the spectral data are determined for each pixel in the image. As biomass 
accumulates on the surface, it induces an additional phase delay in the optical signal. 
Treating the amassing of biomass on the Si02 layer as a growth or increase in the Si02 
thickness with a constant refractive index, the IRIS method is able to measure mass 
buildup with 4 pg/mm2 sensitivity [14]. To quantify the amount of mass bound to the 
surface, a conversion factor from effective Si02 thickness growth to biomass density has 
been experimentally established [71]. 
2.2 Instrument Design 
The key components in designing an IRIS are the chip structure, optical path, camera 
selection, illumination source, and software interface. These items affect the system 
sensitivity, footprint, throughput, and cost. 
2.2.1 Chip Design & Illumination Source Selection 
The IRIS platform spectrally monitors biomass binding to a surface through spectral 
illumination of a chip. The structural design of the chip (material and selected thickness) 
drives the affordability, sensitivity, and robustness of the IRIS platform. Material 
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selection was made with compatibility to high-volume manufacturing processes, existing 
surface chemistries, model complexity, and chemical inertness. Moreover, the spectral 
signature and the resulting phase shifts from biomass binding must be predictable for 
sampling by the illumination source. 
The sample design for IRIS has been selected to be a Si02/Si design in order to 
produce a distinctive, predictable spectral signature. Si02/Si wafers are a standard 
configuration in the integrated circuits industry for CMOS technology. The wide-
availability and demand from the semiconductor market have driven down fabrication 
costs, established fabrication protocols, and high-volume manufacturing. The Si02 layer 
has a similar index of refraction to the biomolecules enabling the 4-layer system to be 
modeled as a 3-layer system with a conversion factor, 1 nm of Si02 for 1.28 ng/mm2 of 
bound BSA [71]. Simplifying the analytical model complexity in this way reduces the 
processing time by 3-fold (0.035 s to 0.01 s per calculation). The final advantage of 
Si02/Si chips is this configuration is compatible with common glass chemistries for 
surface functionalization [72]. 
With the chip configuration, the Si02 layer thickness must be engineered to optimize 
sensitivity and dynamic range of the IRIS platform. This thickness of the Si02 layer is 
also designed based upon with the spectral range and linewidth of the illumination 
source. The thickness of the Si02 layer sets the frequency of oscillation in the reflectance 
curve. The illumination source must be able to accurately sample the reflectance and 
detect the phase shifts from binding for sensitive mass measurements. 
The light source of the IRIS platform provides selective and robust multi-spectral 
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illumination of the chip surface. Wavelength selectivity has the following criteria to 
ensure the reflectance signal is properly sampled over a large range of Si02 thicknesses. 
1) The sampled spectral range includes at least half of a reflectance period. 
2) The spectral sampling rate satisfies the Nyquist rate 
3) At least 3 spectral wavelengths are sampled 
Not adhering to these criteria will result in a higher intrinsic noise floor from the 
diminished accuracy and precision. Spectrally sampling less than half a reflectance curve 
period diminishes the operational range of the platform. Undersampling the reflectance 
curve at the Nyquist rate leads to a SiOz thickness dependent error. When fabricating a 
Si02/Si wafer, the standard protocol is the SiOz thickness will be within 5% of the target 
thickness. The smaller operational range resulting from not following these criteria, 
places a tighter constraint on the manufacturing process that will greatly affect the 
fabrication costs and the quality control procedures. 
Aside from these criteria, the selection of the source is flexible. To a certain extent, 
design choices made in the light source can be accounted for in the Si02 layer design. For 
example, a light source with a fine spectral resolution would be paired with a thicker Si02 
layer (faster varying reflectance curve) to satisfy the wavelength selectivity requirements. 
Additionally, the linewidth of the source must be narrow to resolve the oscillations in the 
reflectance. Looser spectral resolution requires a broad spectral range as the Si02 layer 
thickness would be set accordingly; however, the gentleness of the reflectance curve 
would relax the linewidth requirements of the light source. The tradeoffs between the 
Si02 layer thickness and the illumination source linewidth, spectral range, and spectral 
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resolution is pivotal when designing an IRIS platform. 
2.2.2 Optical Path 
Accurate IRIS measurements require uniform, near-normal illumination of the entire 
image. As the angle of illumination deviates from normal, (}i =0, the error in IRIS 
measurements rises as the analytical model is no longer valid, see Figure 2.2. Additional 
inaccuracy in the IRIS measurements can be presented through non-uniform illumination 
as the signal-to-noise ratio (SNR) of each image is limited by shot-noise [73] . 
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Figure 2.2: IRIS error for multiple angles of incidence. As the angle of incidence deviates from normal, the 
intrinsic error in an IRIS measurement also increases. 
Two prominent optical designs for uniform illumination are Nelsonian illumination 
and Kohler illumination. Both of these optical designs are illustrated in Figure 2.3. 
Nelsonian illumination, also called critical illumination, forms an image of the light 
source on the sample using a condenser lens. The result is a bright, but not always even, 
illumination. Any structure and misalignment in the source will cause gradients or 
hotspots of intensity. Coherent sources with a uniform emission, such as lasers and laser 
diodes, are the most suitable. 
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Kohler illumination provides uniform illumination for non-uniform sources, such as 
arc lamps and LEDs. Developed in 1983, August Kohler proved an incoherent light 
source can project an even intensity on a sample by including additional optics and 
adjustable apertures. This optical configuration controls the angular properties of the 
illumination and projects the Fourier plane onto the sample surface. 
-
-
(a) (b) 
Filament 
Image 
Figure 2.3 : Optical configuration. (a) Nelsonian illumination projects the sample image onto the sample. 
This minimizes the number oflenses but suffers from source artifacts at the sample plane. A diffuser can be 
used for slight improvement. (b) Kohler illumination includes additional optics to project the Fourier plane 
of the illumination onto the sample plane. This approach offers even intensity with no filament artifacts. 
2.2.3 Camera Selection 
The camera of an IRIS instrument is the driving force behind throughput, sensitivity, 
measurement time. Camera selection relies on the several characteristics: full well 
capacity (FWC), frame rate, readout noise, and sensor size. 
IRIS is an imaging technique where each pixel measures the effective Si02 thickness 
of the corresponding surface area. Thus, the throughput of the system is directly linked to 
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the camera's sensor size. It is important to note, however, that a larger sensor is not 
always the answer to throughput. The more pixels within each image proportionally 
increases the image's processing time. As the objects of interest, the protein microarray 
spots, are typically 100 11m diameter circles, it is recommended the pixel resolution (pixel 
size divided by magnification) should be set to approximately 10 11m x 10 11m to 
maximize the field-of-view (FOV). 
Other considerations for camera selection are the FWC, camera noise, and frame rate. 
The accuracy and acquisition time of the IRIS technique is driven by the SNR of each 
image. Reliable IRIS measurements require the SNR of the process spectral data be 400, 
as shown by Figure 2.4. Each acquired image contains shot noise, dark noise, and readout 
nmse. 
2 2 2 2 
a,zoise = a shot + a readout + a dark (2.12) 
Where a;oise is the total variance in the image and a;hot ' a,2eadout ' and a~ark are the 
variances due to shot noise, readout noise, and dark current noise, respectively. 
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Figure 2.4: Image quality effect on IRIS error 
The fundamental variation in the emission of photons from a light source is called 
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shot noise. The other types of noise are the thermal generation of electrons in each pixel 
over time (dark noise), and the frame readout electronic (readout noise). Dark and 
readout noise are set characteristics of each camera, but shot noise is a function of the 
amount of photons collected, N . 
(Jshot = JN (2.13) 
For short exposure times and a single frame acquired, shot noise is the dominate noise 
in the image. A higher SNR can be achieved through a larger FWC and/or averaging 
multiple frames, M. Averaging more frames offers the ability to achieve a higher SNR at 
the expense of acquisition time. 
SNRM = M * FWC = .J M * FWC 
· (J noise ( M) 
(2.14) 
In conclusion, the ideal IRIS camera has a large sensor size, a deep FWC, and a fast 
frame rate. In order to image a large number of spots in every image, the sensor size 
should be as large as possible, but keep in mind the number of pixels affects the 
processing time. To streamline image processing as much as possible, the target pixel 
resolution has been set at 10 ).!ill x 10 ).!ill. This resolution gives a 1 Ox 10 sampling of each 
rnicroarray spot. Finally, each acquired images requires a SNR of 400 for reliability. 
Since IRIS operates in a shot-noise limited regime, the FWC of the sensor determines the 
noise level in each image. Further improvement to the image SNR can be made by 
averaging frames but at the cost of speed. 
2.3 IRIS 1st Generation Design 
The first generation IRIS design, designated the spectral reflectance trnagmg 
28 
biosensor (SRIB), acquires an image of 1000s of biomarkers every 30 seconds [14]. This 
platform utilizes an external cavity tunable laser to spectrally illuminate the Si02/Si chip, 
see Figure 2.5. The illumination path for uniform intensity is a Nelsonian optical design. 
Rotating ground glass units are included in the illumination path to remove speckle 
artifacts from the laser coherence. An external PD monitors the incident intensity for 
fluctuations. A 5 J.lm Si02 on Si chip is used to measure phase shifts. 
Rotating ground -;:;~ 
glass unit Sample 
{a) {b) 
Figure 2.5: IRIS tunable laser system. (a) Schematic of the system. A tunable laser is coupled into an 
optical fiber. The fiber is split with half of the light going to a PD. The other half of the light is randomized 
by rotating ground glass before illuminating the sample. The reflected light is imaged onto a CCD camera. 
The external cavity tunable laser (TLB6300, New Focus, San Jose, CA) provides the spectral illumination 
for measurements. This source has a spectral range of 20 nm at 1 nm increments from 765 nm to 785 nm. 
The linewidth is 1 nm. Coupled with a 5 J.tm Si02/Si chip, this source samples a half period of the 
reflectance curve, see Figure 2.6. To remove spatial coherence artifacts, such as speckle, from the image, 
see Figure 2.7, rotating ground glass discs are implemented. 
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Figure 2.6: Spectral reflectance curve of a 5 Jlm Si02 on Si chip. The vertical lines indicate the external 
cavity tunable laser emission wavelengths. A half period is sampled for accurate fitting. Each wafer costs 
over $200 from SVMI Inc. (Santa Clara, CA, USA). 
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Figure 2. 7: Laser imaging artifacts. In order to disrupt the artifacts, the illumination beam is passed through 
two ground-glass disks, where at least one is rotating. Reprinted from the supporting materials [14]. 
In measuring phase, the magnitude of the incident field needs to be precisely 
measured. Before every experiment, a mirror image is acquired for each wavelength to 
establish the baseline intensity and to correct for spatial fluctuations . Then, an external 
PD is utilized to monitor temporal fluctuations during data acquisition. Before 
processing, the data is normalized by both the mirror image and PD measurements. 
The 1 st generation IRIS system successfully demonstrated proof-of-concept 
experiments; however, in order to commercialize this platform, the component costs, 
system robustness, and instrumentation complexity need to be addressed. The 
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components that have been selected for redesign include the external cavity tunable laser, 
rotating ground glass, and external PD. External cavity tunable lasers are expensive 
sources ($20k) that require periodic alignment. The limited spectral range requires the 
Si02 layer on the sensor chip to be 5 11m increasing manufacturing costs to $200 per 
wafer (25 chips per wafer). The associated power and control electronics are bulky and 
make up the majority of the system's footprint. The coherence artifacts generated from 
imaging with a narrow linewidth source are removed with rotating ground-glass; any 
moving pieces in instrumentation become a potential point-of-failure, thus the need to 
eliminate this component. The external PD increases the system complexity and presents 
an additional point-of-failure mostly resulting from potential misalignment. Eliminating 
these components from the design would reduce the overall system cost, remove multiple 
points of failure, and decrease the footprint to one comparable to an inkjet printer. 
2.4 IRIS 2"d Generation Design 
The second-generation interferometric biosensor, IRIS, implements design changes to 
reduce the size, cost, and complexity without sacrificing sensitivity. The goal of this 
platform was to replace the external cavity tunable laser, eliminate the need for rotating 
ground glass, and remove the external PD. The new platform employs on-chip intensity 
monitoring [15], a multi-wavelength LED illumination source [1], and a new analytical 
model, see Figure 2.8. These improvements have the potential to transform the $30k 
larger first generation IRIS system to a $10k portable platform, see Figure 2.9. 
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Figure 2.8: IRIS Schematic. The 2nd generation platform replaced the external cavity hmable laser, rotating 
ground glass, and external PD with LEDs and an on-chip intensity monitoring to decrease complexity, cost, 
and footprint. 
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Figure 2.9: Evolution of the IRIS platforms. The I st IRIS design used an expensive ( ~$20k) tunable laser 
for illumination and filled a 36 in x 24 in x 24in volume. This platform was then reduced by Zoiray Inc. to 
18 in x 16 in x 6 in prototype with external control electronics. The 2nd generation IRIS instrument design 
implements design improvements to drastically decrease the footprint (9 in x 18 in x 4 in) and cost ($1 OK). 
Boxing the IRIS design into a prototype resulted in a completely automated, compact (7 in x 13 in x 4 in) 
instrument, see Appendix C. 
2.4.1 On-chip Intensity Monitoring 
Accurately measuring the spectral reflectivity reqmres precise knowledge of the 
incident intensity. Typically, the incident beam is divided with one fraction proceeding to 
the sensor surface and the other to an external PD for monitoring [63], [74], [75] . This 
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approach complicates the optical design and decreases the optical efficiency. 
To simplify the optical layout, an on-chip intensity monitoring technique was 
developed [ 15]. The implementation of an on-chip intensity monitoring supersedes using 
an external PD by integrating a surface into each image with a predictable and robust 
signal, see Figure 2.1 0. The trade-off is the negligible loss of area in the image. 
In the case of the Si02/Si chips, the predictable signal comes from bare silicon 
surface. Figure 2.1 Ob illustrates the concept. By patterning the surface using photo-
lithography then wet-etching with buffered-oxide etchant 6:1 (BOE), the surface is 
patterned to expose silicon, as shown in Figure 2.11a. Acting like a mirror, the exposed 
silicon reflects incident light in a predictable way, relative to the incident intensity. 
(a) (b) (c) 
Figure 2.10: Types of intensity monitoring. (a) The beam is split with a fraction proceeding to the chip for 
sensing and a fraction going to an external PD for monitoring (IRIS first generation). (b) and (c) show 
proposed methods of on-chip monitoring. By monitoring an unperturbed region, the signal measured by the 
camera can be used for normalization. Reprinted from [15]. 
The main concern of using an on-chip reference region is maintaining signal fidelity. 
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The on-chip reference region interacts with all the microarray solutions. For the on-chip 
reference region to provide an accurate intensity measurement, the spectral shift should 
not be observed. in the reflection when non-specific binding occurs. Simulations of 
different thickness Si02 layers (0 nm, 5 nm, and 15 nm) on the reference region, to 
emulate 0 ng/mm2, 5 ng/mm2, and 15 ng/mm2 of biomolecular density, show less than a 
1% shift in the reflection, shown Figure 2.11c. 
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Figure 2.11: On-chip intensity monitoring. (a) An image of the surface with the reference in the lower right. 
(b) An illustrative height profile of the Si02 layer along the dashed line from (a). (c) Simulated reflectance 
of the reference region (red) and the Si02 (blue) with 0 ng/mm2 (solid), 5 ng/mm2 (dotted), and 15 ng/mm2 
(dotted dash) ofbiomolecules bound to the surface. Reprinted from [15] 
To assess the performance of the on-chip intensity monitoring region, an end-point 
experiment was conducted on a human serum albumin (HSA) assay. Consecutive 
measurements of a 0.5 mg/mL HSA array were acquired without moving the chip. The 19 
consecutive measurements were repeated while varying the number of images averaged. 
During image acquisition, the intensity fluctuations were recorded both by the reference 
region in the image and an external PD. The performance of no intensity monitoring, 
monitoring by PD, and monitoring by reference region were compared by calculating the 
optical thickness of the HSA spots for each normalization approach. 
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After processing each image, the average density for 15 protein spots were found for 
each monitoring method by subtracting the average of the local background from the spot 
average. The process was completed for each of the 19 scans. Figure 2.12 shows the 
standard deviation of these scans while the number of frames averaged was increased. 
The number of frames averaged was steadily increased for a greater SNR. As 
discussed by Ozkumur [73], the dominating noise for measurements is shot-noise. 
Therefore, averaging images (acquiring more photons) will increase the image SNR. In 
these experiments, if the temporal intensity fluctuations are not properly normalized, the 
error in IRIS measurements will be dominated by noise resulting from temporal intensity 
fluctuation, leading to a higher noise floor. 
As expected, the standard deviation for each approach improved with diminishing 
returns as more frames are averaged. At higher frames averaged, PD and self-reference 
show superior performance over no reference and comparable noise levels to each other. 
The conclusion can be drawn that the temporal intensity noise is corrected comparatively 
whether the reference region or the PD in end-point experiments is used . 
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Figure 2.12: Performance of the intensity monitoring methods. As more frames are averaged, the noise 
floor for each spot improves. The PD and reference region show comparable performance to each other and 
superior performance to the no reference case. Reprinted from [15]. 
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The dynamic protein detection experiment was performed using immobilized bovine 
serum albumin (BSA), rabbit Immunoglobulin G (IgG), and mouse IgG, as shown in 
Figure 2.13a. The chips were secured within a custom flow cell with a 500 ~L capacity. 
IRIS measurements were taken continuously at 1 min intervals. Fifty frames were 
averaged for each image. Each solution was driven over the chip surface using a 
peristaltic pump at 400 ~Limin rate for 15 min/solution. The chamber was first filled with 
1x phosphate buffered saline (PBS) followed by anti-mouse IgG at 10 ~g/mL, another 1x 
PBS wash, and then anti-rabbit IgG at 10 ~g/mL. The PBS washes remove unbound 
material and flush the flow cell for the next incubation. For analysis, every data set has 
the Si02 thickness extracted for the three monitoring techniques. 
(a) 
20 40 
Time (min) 
(b) 
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Figure 2.13: Dynamic detection of IgG binding. (a) Cropped image showing the assay geometry. The 
reference region is not shown. (b) The measured binding using the three methods of intensity monitoring. 
(c) Standard deviation of the data for the three methods of normalization during minutes 31-40. During 
these time points, binding has reached saturation. Therefore, fluctuations in the data are from the system 
noise. Reprinted from [15]. 
, Analyzing the resulting curves shows both noise normalization tactics perform better 
than no normalization. As shown in Figure 2.13b, the no reference approach has more 
noise than self-reference and PD. Examination of the anti-mouse incubation at minutes 
31-40, see Figure 2.13c, shows the reference region noise reduction was even greater than 
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the external PD. In this case, the PD does not account for the buffer effects, such as 
adsorption and scattering, resulting in greater performance from the on-chip reference. 
In summary, both end-point and dynamic monitoring show the on-chip reference 
provides accurate monitoring of the incident intensity. For end-point experiments, 
whether the intensity monitoring is conducted by an external PD or on-chip region, a 
similar noise level can be attained. However, real-time binding analyses will see lower 
noise levels with on-chip reference regions for high-sensitivity measurements. 
2.4.2 LED Illumination 
The first generation IRIS platform utilized an external cavity tunable laser to 
spectrally illuminate the surface over a 20 nm range. This type of illumination source is 
expensive, requires a stable environment, and necessitates rotating ground glass discs to 
overcome speckle artifacts. In order to decrease the platform's complexity, fragility, and 
component prices, the external cavity tunable laser was exchanged for discrete LED 
devices. 
LEDs are semiconductor light sources formed from direct band gap p-n junctions. 
These sources are mechanically robust, spatially incoherent, and low-cost. For multi-
spectral illumination, multiple LEDs can be mounted adjacently on the same LED 
package, see Figure 2.14. This "Design-Your-Own" configuration allows custom 
selection of the wavelengths and each LED can be individually powered or all 
illuminated simultaneously. For the IRIS platform, the wavelengths selected are 455 nm 
(blue), 518 nm (green), 598 nm (yellow), and 635 nm (red) . . 
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Figure 2.14: Excelitas ACULED VHL Red-Yellow-Green-Blue LED Package. Reprinted from 
www.excelitas.com. Accessed on 9/25/2013. 
Incorporating the LEDs in the IRIS system also involves redesigning the optical 
illumination path and the Si02/Si chip configuration. While the illumination source is 
changing, the same parameters described in Section 2.2.1, still govern the basis for the 
IRIS model; however, integration of an LED introduces modifications that invalidate 
assumptions in the original optical model. In a Nelsonian illumination configuration, the 
structure of the LED surface will be projected onto the sample resulting in illumination 
non-uniformity. Moreover, the LEDs are not directly on the optical axis, thus the spatial 
deviation from the optical axis will create intensity gradients in the image. Lastly, the 
broad spectrallinewidth of LEDs invalidates the IRIS analytical model, which assumes a 
narrow illumination linewidth. Not accounting for the broad spectrallinewidth introduces 
error. 
To alleviate intensity non-uniformity issues, the optical path has been reconfigured 
into Kohler illumination with a diffuser. The Kohler illumination optical design provides 
constant intensity across the imaged plane for incoherent, non-uniform emission sources. 
Including a diffuser between the collection lens and the LEDs introduces a spatial mixing 
to reduce effects from the co-located LEDs. As shown in Figure 2.15, implementing this 
optical configuration provides speckle-free illumination with less than 3% variation in the 
image intensity. 
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Figure 2.15: Illumination quality of LEDs with a Kohler optical configuration. (a) An IRJS image of a 
microarray. The inside square is the Si02 with spotted protein. The border is the reference region for on-
chip intensity monitoring. Note there is no speckle. (b) The intensity histograms from imaging a mirror for 
each LED. The enactment of a diffuser and Kohler illumination gives each LED an even intensity profile ( < 
3% standard deviation for each LED). The x-axis shows the pixel fill percentage (pixel count normalized 
by camera bit depth). 
In order to ensure the LEDs are able to sense the phase shifts from biomass 
accumulation, the Si02layer thickness must be engineered to optimize sensitivity. For the 
external cavity tunable laser, a 5 J.lm Si02 layer set the reflectivity oscillations at a 
frequency conducive to imaging with a 1 nm linewidth source over a 20 nm spectral 
range, as shown in Figure 2.6. For the LEDs, the 5 f..Lm design will not suffice. These 
sources have a broader spectral range and linewidth, as shown in Figure 2.16a. Thinning 
the Si02 layer to 500 nm decreases the frequency of oscillation for spectral sampling, see 
Figure 2.16b. 
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Figure 2.16: Si02/Si reflectivity curves. (a) Reflectivity curve of a 5 Jlill thick Si02 with the LEDs ' 
linewidth overlaid. (b) Reflectivity curve of a 500 nm thick Si02 with the LEDs' linewidth overlaid. 
The final aspect to account for is the linewidth of each LED. Discussed in 2.1, the 
current IRIS analytical model assumes a narrow linewidth illumination. Current 
commercial LEDs have a 10 nm - 30 nm spectrallinewidth that can be approximated by 
a Gaussian. As seen in Figure 2.17, the reflectance between a 1 nm linewidth and a 10 nm 
or 30 nm linewidth is easily noticeable for a 500 nm Si02/Si chip. Therefore, ignoring the 
spectrallinewidth of a LED will lead to erroneous IRIS data. 
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Figure 2.17: Calculated reflectance of a 500 nm Si02/Si chip for a 1 nm linewidth source and (a) a I 0 nm 
Gaussian linewidth source or (b) a 30 nm Gaussian Iinewidth source. LEDs typically have a non-symmetric 
Gaussian-like profile with a linewidth ranging from 10 nm to 30 nm. These calculations show the linewidth 
of the LEDs do significantly alter the reflectance. 
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To correct the linewidth inaccuracy in the analytical model, the IRIS model must be 
more sophisticated. It is necessary to integrate the reflectance over the spectral linewidth 
for each LED. 
(2.15) 
From an analytical viewpoint this is a near-trivial modification; however, the 
computational complexity for the new model is significantly increased. The SRIB model 
was calculated once for each wavelength. This new method must calculate the reflectance 
for .the discrete steps of the LED's spectrallinewidth and then execute a Riemann sum: 
- '2k d 
".H r + r e 1 z,, 
R = "fJ I 1,11 2,11 12 
L...J 11 1 - j 2k d 
11=0 + rlllr2 "e z,, 
(2.16) 
Where /]
11 
is the spectral weight for n A. samples of the LED spectral linewidth. The 
computation required for this model is directly proportional to the sampling of the LED 
linewidth. Currently, the linewidth is sampled at over 330 discrete points for each LED. 
While the device itself is more suitable for low-cost portable implementations, the 
processing necessary to compensate for the design changes greatly limits the utility. As 
shown in Table 2.1, a single computer requires in excess of 4 hours processing for a 2 
megapixel image. One laboratory-based solution is to divide the image across a large 
computing grid for parallel processing. This is not appropriate for most applications. 
Noticing each pixel in the image is independent from its neighbors but undergoes the 
same arithmetic, a graphics card algorithm has been written to parallelize the processing 
on a single computer [76] , discussed further in Appendix D. 
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Table 2.1: IRIS processing time for multiple hardware methods. 
Hardware Type 
Single CPU Grid of i7-920 Graphics Card Graphics Card 
i7-920@ 2.67GHz CPUs GTX 285 GTX 680 
Processing time (2MP) 15785.0 sec 322.2 sec 174.0 sec 39.5 sec 
2.4.3 IRIS Chip Fabrication 
The reference patterns required for on-chip referencing are fabricated usmg 
photolithography patterning, processing, and wet-etching. Si02/Si wafers with 500 run of 
thermally grown Si02 are purchased from Silicon Valley Microelectronics (Santa Clara, 
CA). The surface is cleaned of organic residue by sonicating in acetone for 10 minutes 
and plasma ashing in an oxygen environment at 300 seem and 500 W for 10 minutes. For 
patterning, hexamethyldisilazane (HMDS) and Shipley S 1813 positive resist are spun 
onto the surface at 2000 rpm for 30 seconds followed by a soft bake at 90 °C for 3 
minutes. Next, the chip is exposed to UV light for 30 seconds at 15 mW in the SUSS 
MA6 Mask Aligner and a custom designed photolithography mask. The exposed wafer is 
developed for 45 seconds in Micro-Dev resist developer diluted 1:1 with deionized (DI) 
water, and hard baked for 5 minutes at 120 °C. 
Once the pattern has been transferred from the mask to the photoresist on the wafer, 
the surface must be etched. BOE selectivity etches Si02 over Si at a rate of 77 nm/min. 
To expose the underlying Si layer, the wafers are submerged in BOE for 7 minutes, 
utilizing the Si layer as a natural etch stop. Over etching cannot occur since BOE does 
not attack the silicon surface. 
With the pattern transferred to the chip surface, the photoresist is stripped from the 
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surface following the same procedure to strip orgamcs (sonication in acetone for 10 
minutes and oxygen plasma ash at 300 seem and 500 W for 10 minutes). A new layer of 
S 1813 photoresist is spun on then hard baked. This layer will protect the wafer surface 
during the dicing process. The covered wafer is diced into 15 mm x 15 mm chips using a 
Disco dicing saw. Finally, the protective photoresist layer is stripped using the organic 
removal procedure previously described. Figure 2.18 shows a single chip with the IRIS 
pattern. 
Figure 2.18: A 15 mm x 15 mm IRIS chip with 500 run ofSi02. The chip is divided into four Si02 
quadrants (purple) to allow a reference region (gray) to be captured in every image. The coloring of the 
Si02 is a function of the layer thickness. 
2.5 Instrument Validation Procedure 
The 2nd generation IRIS design decreases the complexity and cost enabling potential 
for the commercialization of the technology. Each platform constructed must have an 
instrumentation performance validation process. This section details the standard 
calibration protocol for ensuring the performance of IRIS platforms. The standard 
procedure will tune the intensity of the LEDs, measure the LEDs' linewidth, construct the 
spectral weight function for the IRIS model, and validate performance with artificial non-
biological samples. 
As discussed in Section 2.2.2, the quality of illumination (uniformity and strength) 
affects the signal accuracy. The target uniformity and strength for each LED is a standard 
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deviation less than 5% at 60% FWC. To guarantee a high SNR image, the LED 
intensities are adjusted to 60% of the camera's FWC. This procedure aligns the intensity 
of each LED using a custom PCB board. This PCB board has been designed to provide 
each LED a constant current,' see Figure 2.19. To begin, a bare Si chip (a mirror) is 
placed on the sample platform and brought into focus. Using the histogram function, the 
intensity profiles of each LED are aligned by tuning the potentiometer on the circuit 
board. Since the yellow LED has the lowest efficiency, it is recommended the yellow 
LED current be maximized and used as the baseline for the other LEDs. If the width of 
the intensity profile exceeds 5% standard deviation, there is a misalignment in the 
system. System alignment is performed by leveling the illumination path, sample 
platform, and imaging path. Fine adjustment can be completed with feedback from the 
image gradients. 
Cl 
OOn 
VDD 
Pins to LEDs 
PinstoDAQ 
Figure 2.19: IRIS LED Current PCB. The circuit can be powered by a USB connection, barrel power 
connector, a 2-pin connector, or the data acquisition (DAQ) device's 6-pin connector. Each LED is 
interfaced with a TIA242 LED driver to provide a constant current up to 500 rnA. A potentiometer is 
coupled to the reference pin of the TIA242 for tuning the current. The LEDs are individually toggled on/off 
using a push button, dip switch, or DAQ device. 
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With the system aligned and the LEDs tuned, the LED profile must be captured, 
normalized, and integrated into the IRIS processing software. This is done by aligning the 
input fiber of a spectrometer (USB 2000, Ocean Optics, Florida, USA) to the sample 
plane and bringing it into focus. First, the dark spectrum is acquired and then each LED is 
sequentially illuminated and the spectral profile captured. For a high SNR, the exposure 
time is adjusted to fill the detector to 70% of the FWC and average at least 10 
measurements. The composite profile is saved to a text file. The text file is loaded into 
MATLAB and the integral of the profile is normalized to 1. Finally, this profile is saved 
into a mat-file ([instrument name].mat) using the correct variable names (wavelength, 
step_ wavelength, and weight). The spectral mat-file can now be integrated into the IRIS 
processing software, MGrid. Note, when implementing new instruments, the 
GRID _initGrid.m and fitdata.m files must be updated. 
After implementing the new system's linewidth profile in the IRIS processing 
software, the calculation of Si02 thickness must be verified. First, a calibration sample 
should be fabricated. Starting with a 500 nrn Si02/Si chip, etch patterns into the surface 
to emulate biomass binding. Next, measure the absolute Si02 thickness for each depth 
with ellipsometry and/or atomic force micro~copy (AFM). Finally, acquire IRIS images 
and compare. (Figure 2.20 shows the analysis method for fitted IRIS data.) For the first 
2nd generation IRIS instrument, a 0.06% and 4.97% percent error was observed when 
comparing results from ellipsometry and AFM, respectively. The discrepancy between 
the AFM and IRIS measurements comes from substrate bowing in the AFM results [77], 
see Figure 2.21. 
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Figure 2.20: Fitted IRIS Image Processing. The average of the spot (green circle) is subtracted from the 
average of the local background (red ring) to determine the effective Si02 thickness of the biomass. The 
thickness due to the biomass is then converted into density using the quantification factor. 
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Figure 2.21: AFM measurement of the calibration sample. (a) AFM image. (b) Profile of step. The red 
arrows indicate the two points analyzed to determine the vertical distance. The points analyzed were 
selected to minimize effects from AFM induced bowing artifacts [77]. The percent error between the IRIS 
(8.644 nm with a 19 pm standard deviation) and the AFM results is 4.97%. 
2.5.1 Quantifying Surface Mass Density 
The principle of IRIS detection is the quantification of bio-mass accumulation on the 
surface. The IRIS method relates the bound density to a growth (or increase) in the Si02 
layer thickness. Since Si02 and the biomass do not have identical refractive indices, the 
phase delay induced by mass accumulation does not have a 1-to-1 relationship to the 
growth in Si02 thickness measured by IRIS. Ozkumur et al. demonstrated the 1st 
generation IRIS instrument had a BSA conversion factor of 1.21 ng/mm2 for 1 nm of 
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Si02 [71]. These experiments have been repeated for the 2nd generation IRIS platform. 
Determining the response of the system to the adsorption of mass to the surface 
requires precisely spotting a known quantity of mass onto the surface. Described in detail 
in Appendix A, the response ofthe system to 25 pg to 400 pg of mass on the surface was 
quantified using purified BSA (Sigma, St. Louis, MO). As shown in Figure 2.22, the 
effective Si02 thickness from the spotted mass has been extracted for the 3 x 6 array of 
BSA. The measured IRIS signal has been scaled by the analyzed area to account for the 
variable spot size. From the inverse slope of the linear fit, a relationship between the 
surface density and measured optical thickness is calculated to be 1.3 ng/mm2 for 1 nm of 
Si02 thickness [1]. This calibration factor is 8% higher than the previous value. The 
difference between factors is attributed to user variation in the experimental preparation 
process, such as inaccuracies in the preparation of the known protein solutions. 
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Figure 2.22: IRIS quantification of protein adsorption to the surface. (a) Processed grayscale image ofBSA 
spotted at different masses. (b) Plot of weighted sum of material thickness show the linearity of the system. 
The weight sum is calculated by multiplying the thickness of the spot and spot area. The error bars reflect 
±1 standard deviation for 18 replicate spots. Reprinted from [1]. 
To conclude, the 2nd generation IRIS platform builds upon the 1st generation design to 
decrease the system component costs and complexity, while increasing robustness. The 
external PD has been substituted with an on-chip reference region. Experiments validated 
that the on-chip reference region achieves a similar noise floor to the PD. The external 
cavity tunable laser has been exchanged with a 4 LED source. This substitution removed 
the speckle artifacts from the spatial coherence of the laser and the need for rotating 
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ground glass. In order to implement the LEDs, the Si02/Si chip has been thinned from 5 
jlm to 500 nm - reducing the cost per wafer 10 fold- and the IRIS analytical model has 
been modified to include linewidth. Quantification experiments have been conducted to 
determine the LED IRIS optical thickness to mass density conversiOn factor (1.3 
ng/mm2). Finally, a standard calibration procedure has been established for system 
alignment and validation. 
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Chapter 3 
MULTI-MODAL MICROARRAY DETECTION 
Although the IRIS platform has been proven to be quantifiable and sensitive in 
protein detection, the technique cannot discriminate specific from non-specific binding in 
clinical samples. Fluorescence imaging, a labeled detection technique, is not susceptible 
to this problem, because it uses additional bioreceptors to increase signal specificity. The 
drawback to labeling, however, is the loss of information about the microarray quality. 
For complex molecules, like proteins, the density of immobilized probe varies resulting 
in noisy fluorescence data from experiment to experiment. In order to strengthen both 
techniques, a hybrid label-free/label detection method has been developed. This approach 
takes advantage of the quantification of IRIS and specificity of fluorescence imaging for 
sensitive and robust clinical microarray assays. 
This chapter discusses the fusion of IRIS with fluorescence imaging for dual-
modality detection. This new method, termed CaFE, facilitates rapid microarray 
development [ 4] and achieves inter-experiment linearity by relating the fluorescence 
response to the surface-bound probe density. Two Si02/Si designs aimed at broadband 
and selective fluorescence enhancement are described. Finally, the practically of the 
CaFE technique is proven with the design of an integrated dual-modality microscope. 
3.1 Calibrated Fluorescence Enhancement Si02/Si Chips 
In order to provide IRIS and wide-field fluorescence measurements, a common chip 
design has been implemented [78] . The standard chip design for fluorescence imaging is 
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a glass slide. Attempts to replace the standard glass slide have led to enhancement 
techniques with photonic crystals [53], [79] , plasmonic metal layers [80], [81], 
nanoparticles [82], [83] , and dielectric spacer configurations [84]-[87]. However, the 
glass slide is still the standard for its low-cost, low auto-fluorescence, design simplicity, 
and compatibility with established surface chemistries. The Si02/Si chips used by IRIS 
are able to compete with glass slides on all these metrics with the added benefit of 
enhancing the fluorescence signal beyond glass [ 61]. 
Two Si02/Si design have been pursued for IRIS and fluorescence imaging. The ONC 
chip design aims to yield emission enhancement for maximum coverage of wavelengths 
while performing label-free sensing on a separate spot on the same chip. This chip design 
relies on spotting repeatability within a chip in order to allow for optimized label-free and 
broadband fluorescence sensing on different Si02 regions. The CLC chip design remedies 
potential issues with intra-chip array spotting consistency by performing a same spot 
analysis. This approach consists of a single Si02 thickness for IRIS analysis and selective 
enhancement of Cy3 and Cy5 fluorophores. These configurations facilitate the use of 
IRIS and fluorescence imaging modalities to calibrate for inter-chip and intra-chip 
variations. 
3. 1 .1 Chip Design 
Selection of the Si02 thickness for the ONC and CLC designs were carried out using 
the dipole emission model for an interferometric chip [2] , [88], [89]. In Figure 3.la, the 
calculated fluorescence signal at 0.7 NA for a 100 nm and 320 . nm Si02 layer is 
compared with glass. The 100 nm Si02 design offers the broadband enhancement and 
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will be coupled with 500 run Si02 regions for the ONC design. The 320 run design 
provides both selective enhancement of both Cy3 and Cy5 and IRIS measurements. In 
Figure 3.1 b, the NA dependence of emission enhancement of Cy3 is plotted for the two 
optimized designs. As expected, the 320 run Si02 layer provides a smaller enhancement 
to the signal, but both designs provide higher fluorescence signal than glass. 
The 320 run Si02 design must also be able to provide accurate label-free IRIS 
measurements for same spot imaging. As shown in Figure 3.2a, the reflectance curve 
satisfies the design criteria laid out in Section 2.2.1. IRIS Monte Carlo simulations, 
Figure 3.2b, confirm the 320 run chip will provide similar performance to the IRIS chip. 
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Figure 3.1: Labeled evaluation of CaFE chip designs. (a) The fluorescence signal profile ofthe two Si02/Si 
designs with respect to glass. Notice the 100 nrn Si02 design increases the signal across the visible while 
320 nm Si02 selectively enhances Cy3 and Cy5. (b) The calculated fluorescence enhancement for the 2 
designs with respect to glass. 
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Figure 3.2: Label-free evaluation of CaFE chip designs. (a) Reflectance curve for 500 nrn, 320 run, and 100 
nm Si02/Si chips. According to the chip design criteria discussed in Section 2.2.1, 320 nm is expected to 
have more accurateiRIS measurements than 100 nm. (b) The absolute error in Si02 thiclmess calculations 
for the LED IRIS platform. As expected, the noise levels in 100 nm are twice as great as 320 nm and 500 
run. 
3.1.2 Fabrication Procedure 
The CaFE chip comes in two designs. The ONC design has two Si02 areas: (1) a 500 
nm thick Si02 region dedicated to IRIS quantification and (2) a 100 nm thick Si02 region 
to provide enhanced fluorescence. The CLC design contains a single Si02 region at 320 
nm thick for both measurements. Starting with a 320 nm Si02/Si wafer, fabrication of the 
CLC design follows the procedure outlined in Section 2.4.3. To fabricate an ONC wafer 
the following procedure is outlined below. 
Starting with an IRIS patterned wafer- see Section 2.4.3 for fabrication details -
select Si02 islands must be etched to 100 nm for fluorescence enhancement. 
Photolithography is used to transfer the mask pattern to the chip surface for selective wet 
etching. Acetone and oxygen plasma-ash are used to clean the surface of organic residue. 
HMDS and Shipley S 1818 positive resist are spun onto the surface. The patterned is 
transferred to the photoresist with contact photolithography. Etching the exposed Si02 
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from 500 run to 100 run is performed with BOE 6:1 diluted 1 :40 with DI water to achieve 
an etch rate of 4 run/min. The ellipsometer (VASE ellipsometer, J.A. Woollam Inc., 
Lincoln, NE), is used to verify the Si02 thickness. Finally, the wafer is cleaned and 
prepped for dicing. 
In Figure 3.3 the ONC chip, applied to allergen microarrays, is illustrated. The chip is 
15 mm x 15 mm and divided into four quarters (Figure 3.3a), three regions have been 
etched to 100 run thick Si02 and one region has a 500 run thick Si02• Each quarter of the 
chip was spotted with the same protein array within the same spotting session. After 
binding proteins and blocking unreacted sites, the quarter of the chip exhibiting the 500 
run Si02 layer was imaged using IRIS. The immobilized density for each condition is 
quantified; the morphology and consistency of spots are also verified by visual 
inspection. The chip was then incubated first with serum samples containing allergen 
specific immunoglobulin E (IgE) and then with fluorescent anti-IgE antibody. Next, the 
100 run Si02 quadrants were analyzed in a fluorescence scanner for quantification of 
fluorescent signals. Figure 3.3b shows the composite image obtained, for the same 
allergen microarray, before the serum incubation (label free detection of immobilized 
allergens) and after incubations with an allergic patient's serum and fluorescent 
secondary antibody. 
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(a) (b) 
Figure 3.3: Fluorescence/IRIS chip design. The Si02/Si chip is a 15 mm x 15 mm square divided into four 
quadrants (a). Quadrants 1, 2, and 3 exhibit a Si02 layer of 100 nrn for fluorescence and quadrant 4 is a 
Si02 thickness of 500 nrn. Each quarter of the chip is spotted with the same protein array within the same 
spotting session. The quarter of the chip exhibiting the 500 nrn Si02 layer is imaged by IRIS. The other 
three quarters are analyzed by a fluorescence scanner. (b) A composite image obtained, for the same 
allergen rnicroarray, before the serum incubation (label free detection of immobilized allergens) and after 
incubations with an allergic patient's serum and fluorescent secondary antibody. 
3.2 Microarray Calibration Proof-of-Concept 
Detection of allergen-specific IgE molecules necessitates the use of secondary 
antibodies to distinguish them from the large amount of physiologic allergen-specific IgG 
molecules that bind to the probe but are not indicative of allergic sensitization. The 
additional quantification challenge imposed by the large variability in immobilized probe 
density makes in-vitro allergy diagnostics a perfect candidate for the demonstration of 
CaFE technology [2] . 
The experiments conducted in this section are perfonned usmg 2 separate 
instruments, the LED IRIS platform and a fluorescence reader (GenePix 4000B, 
Molecular Devices LLC, Sunnyvale, CA, USA). 
3.2.1 Assay Preparation 
To demonstrate the universal application of the CaFE method, we have performed the 
quantification and correlation of captured IgG and ~-lactoglobulin probe to fluorescence 
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signal of Cy3-labeled-secondary antibody. For these experiments, ONC chips are used 
for optimized fluorescence and IRIS sensitivity. IgG and ~-lactoglobulin proteins were 
selected for their well-established spotting protocols and reliable spotting morphologies. 
IgG Procedure. As a proof of concept, 20 replicates IgG of varying concentrations 
(0.015, 0.03, 0.063, 0.125, 0.25, and 1 mg/mL) were spotted onto 2 chips. After overnight 
humid chamber incubation, the chips were washed with 50 mM ethanolamine in 
TRIS/HCl 1MpH 9 for 1 h, rinsed with water, dried with a stream of Argon gas, and then 
measured using IRIS. They were then incubated with 100 J.LL of specific labeled antibody 
in incubation buffer (Tris/HCl 0.05M pH 7.6, NaCl 0.15M, Tween 20 0.02%) with 1% 
w/v BSA for 1 hat 1 J.Lg/mL. Another IRIS measurement was taken after washing with 
PBS for 10 min, rinsing with water, and drying with Argon. 
Fluorescence evaluation was performed by a fluorescence scanner usmg 40% 
photomultiplier tube (PMT) gain and 33% laser power for maximum fluorescence value 
without saturation. Mean fluorescence intensity and standard error from all 20 spots is 
depicted. 
0-Lactoglobulin Procedure. To model a sandwich assay similar to the allergen 
immunoassay and to demonstrate the versatility of the CaFE method, 20 replicates of ~­
lactoglobulin of varying concentrations (0.015, 0.03, 0.063, 0.125, 0.25, and 1 mg/mL) 
were spotted onto three chips. After overnight humid chamber incubation, the chips were 
washed with 50 mM ethanolamine in TRIS/HCl 1 MpH 9 for 1 h, washed with water, 
dried with a stream of argon gas, and then measured using IRIS. Then, the chips were 
incubated with 100 J.LL of specific antibody in incubation buffer with 1% w/v BSA, for 
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2hr at 10 ng/mL. Next, the chips were washed with washing buffer (Tris/HCl 0.05 M pH 
9, NaCl 0.25 M, Tween20 0.05%) for 10 min, rinsed with water, and dried with Argon 
gas. Following drying, the chips were incubated with 100 J.!L of the solution of the 
specific labeled secondary antibody 1 Jlg/mL in incubation buffer for 1 h. Finally, the 
chips were washed with PBS for 10 min, rinsed with water, dried with Argon, and 
measured with IRIS. 
Fluorescence evaluation was performed using 90% PMT gain and 90% laser power 
for maximum fluorescence value just below saturation. Mean fluorescence intensity and 
standard error were plotted for the 20 replicate spots. 
Allergen Procedure. To evaluate CaFE as a clinical diagnostic platform, two major 
allergens, peanut (Ara hl) and timothy grass (Phl p 1 ), were spotted in replicates of three 
at four concentrations (0.25, 0.5, 0.75, and 1.0 mg/mL) on two ONC chips. In addition, 
PBS and IgG were spotted as negative and positive control parameters. After overnight 
humid chamber incubation, the chips were washed with 50 mM ethanolamine in 
TRIS/HCl 1 M pH 9 for 1 h, washed with water, dried with a stream of Argon gas, and 
then measured using IRIS. The chips were then incubated with 100 JlL of patient serum 
with documented allergy to peanut (specific IgE 19.40 kU/L, Phadia ImmunoCAP) and 
timothy grass (positive allergen skin prick test) in incubation buffer with 1% w/v BSA for 
2 h at 10 Jlg/mL (Subject recruitment was approved by the Boston University Medical 
Campus Institutional Review Board, ProtocolH-29428.). Another wash was applied with 
washing buffer for 10 min, followed by a rinse with DI water and drying with Argon gas. 
After incubating with 1 ng/mL anti-IgE labeled with Cy3, the chips were washed with 
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PBS (1 0 min), rinsed with DI water, dried with Argon, and measured with IRIS. 
Scanning for fluorescence evaluation was performed with 90% PMT gain and laser 
power to maximize the signal-to-noise ratio without pixel saturation. 
3.2.2 Results and Discussion 
lgG and 0-Lactoglobulin Calibration. Images of both label-free measurements 
(Figure 3.4a) and fluorescence measurements (Figure 3.4b) show a gradient that 
correlates with varying concentration of immobilized rabbit IgG and captured Cy3-anti-
rabbit IgG. The fluorescence enhancement ofthe 100 nm Si02 islands is noticeable when 
compared to the 500 nm Si02 island. Similar effects are seen in the ~-lactoglobulin array 
but are not shown. 
Theoretically, each chip should bind the same probe density on the surface. IRIS 
measurements show that both IgG and ~-lactoglobulin exhibit large immobilization 
variation between chips resulting in varied fluorescence measurements. Quadrant-to-
quadrant variation on chip was also present in the IgG data. After applying the CaFE 
method, see Figure 3.4c, d, each protein demonstrates a calibrated, strong linear response 
(R2 >90%) between the fluorescence signal and probe density despite the chip-to-chip 
variability. The slopes of the calibrated curves differ because each protein has different 
finite binding capacities. Overall, these results suggest that the CaFE method will be an 
effective and versatile platform to quantify and correlate the probe density to the 
fluorescence signal. Going one step further, inter-grid variation could be addressed by 
implementing the CLC chip design, which would assess each spot individually. 
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Figure 3.4: CaFE CLC chip concept. (a) Label-free IRIS image of varying concentrations of rabbit IgG on 
the 500 nm island of CLC chip. (b) Fluorescence image of spotting array on ONC chips for varying 
concentrations of captured Cy3-anti-rabbit lgG. (c) CaFE measurement for rabbit IgG and (d) P-
lactoglobulin. Error bars represent the standard deviation of 20 spots. For the lgG calibration of Chip 3, two 
quadrants (Ql and Q2) are analyzed to show on chip variability. Results show the CaFE method yields 
calibrated, linear responses between experiments for a variety of proteins. 
Allergen Assay Calibration. The performance of the two chips, defined by the 
fluorescence signal from secondary IgE, varies between the allergens because different 
levels of IgE exist in serum for each particular allergen. When analyzing the fluorescence 
signal of anti-IgE in the fashion of a typical ELISA and microarray assays, measurement 
variation of allergen-specific IgE of the same allergen between chips is seen, particularly 
for Phi p i allergen (see Figure 3.5a). The degree of chip-to-chip variation between 
allergens most likely occurs because of the physiochemical properties of the allergens 
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themselves (i.e., affinity to immobilize to the surface) and technical variation (i.e., 
spotting). While only slight chip-to-chip fluorescence variations are seen for Ara hl 
allergen (R2 of 0.88), a significantchip-to-chip fluorescence variation is seen for Phl pl 
allergen (R2 of 0.24), despite the same conditions, reagents, and serum samples used in 
this single experiment. On the basis of the fluorescence data alone, it is unknown as to 
why Phl p 1 allergen chips yield different fluorescence responses. 
To account for this deviation, the CaFE method is applied to collected fluorescence 
and IRIS data. As a result, a calibrated, linear response between allergen-specific IgE and 
amount of allergen immobilized on surface emerges (see Figure 3.5b ). In both the Ara hl 
and Phl p 1 examples, the R2 value increases to at least 90%, demonstrating the higher 
degree of correlation between fluorescence signal and immobilization density compared 
to spotting concentration. Although the CaFE method only slightly improves upon Ara hl 
allergen data, the effects of including label-free IRIS measurement are dramatically seen 
in the Phl p 1 data. Most importantly, use of the CaFE method clarifies that higher 
immobilization density of Phl p 1 allergen on chip 2 results in higher fluorescence signal, 
indicating that any variation in immobilization density will affect the amount of IgE 
captured. In accordance with the literature, this data supports that high variation in 
allergen immobilization microarrays is a concerning issue [90]. The strong linear 
correlation between fluorescence and immobilization density demonstrates the value of 
the CaFE method as an opportunity for calibrated quantitative assessment of serum 
allergen-specific IgE and should improve accuracy in predicting clinical reactivity in 
susceptible individuals. 
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Figure 3.5: Calibration of the fluorescence response. (a) The standard "calibration" of secondary antibody 
for diagnosis of allergy is measured as the degree of fluorescence as a function of spotting concentration is 
shown for Ara hI peanut allergen (left) and Phi pi timothy grass allergen (right) for two chips. (b) Using 
CaFE, results show calibrated, linear responses for allergy testing analysis compared to traditional "semi-
quantifiable" analysis in part a. 
3.2.3 Conclusions 
Relying on the consistent immobilization of probes for every assay inherently 
introduces error. As shown in Figure 3.5, the spotted concentration is neither indicative of 
the bound density nor the resulting fluorescence signal. The disagreement between the 
fmal fluorescence signals comes from the immobilized density that varies by protein and 
spotting run. Correlating the fluorescence signal to the immobilized probe density regains 
linearity despite chip-to-chip variance. The application of the ONC chip design has been 
demonstrated with an IgG, ~-lactoglobulin, and allergen assay. Further improvement to 
account for grid-to-grid variance is shown to be possible through the utilization of the 
61 
CLC design for same spot calibration. 
3.3 Integrated Instrument for Calibrated Fluorescence Protein Microarrays 
The CaFE method has shown using a label-free in conjunction with a labeled method 
is able to increase reproducibility between fluorescence microarrays by correlating the 
fluorescence signal to the surface-bound probe density [2]. The initial CaFE experiments 
utilized an IRIS instrument to measure the probe immobilization and a separate 
fluorescence reader to measure the fluorescence signal from fluorophores linked to 
secondary bioreceptors. If these instruments can be integrated, the labor and 
instrumentation costs associated with this method of calibration can be reduced. This 
section . details the hardware and software design for a combined apparatus [ 16]. 
Ultimately, this work can lead to a modular attachment for commercial wide-field 
fluorescence imagers. 
3.3.1 Optical Design 
The first step in design an integrated platform is analyzing the design requirements 
and points of synergy between the modalities. From an optical design standpoint, IRIS 
and wide-field fluorescence imaging have several points of symmetry and two 
dissimilarities. Both platforms are top-illuminated, also known as reflection-mode, 
microscopes. For reliable data collection, these instruments require uniform and stable 
illumination of the sample across the FOV. The caveats requiring attention are 
fluorescence imaging necessitates spectral filters and a high NA collection. 
Fluorescence imaging optimizes sensitivity by maximizing the illumination intensity 
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at the fluorophore plane and then spectrally filters all non-signal wavelengths in the 
imaging path to nullify background signals. To achieve spectral isolation, an excitation 
filter, a dichroic mirror, and an emission filter are built into the optical path. Figure 3.6 
illustrates the ideal spectral design of the fluorescence filters. The excitation filter, 
typically a short-pass filter, is placed in the illumination path to eliminate any overlap 
between the illumination spectrum and the detection spectrum. The emission filter, 
typically a long-pass or band-pass, filter is in the imaging path to block signal from the 
illumination and external sources. For additional spectral isolation and greater 
illumination/imaging efficiency, fluorescence imaging utilizes a long-pass dichroic 
mirror instead of a beamsplitter. 
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Figure 3.6: Transmission spectra of Select Cy3 Filters. The absorption spectrum of Cy3 is from 500-550 
run. The emission spectrum extends from 550 - 600 nm. The emission and excitation filters were selected to 
spectrally isolate the illumination and fluorescence signals for filtering. The dichroic mirror reflects the 
excitation wavelengths and transmits the emission wavelengths for high excitation intensity on the sample 
and high efficiency of the emission path for the fluorescence signal but not the excitation signal. 
Taking into account the requirements of the modalities, the hybrid instrument has 
been designed as shown in Figure 3.7. IRIS illumination is provided by the 4-LED 
package (ACL01-MC-RGYB-E08-C01-L-OOOO, Excelitas Technologies, Waltham, MA, 
USA). A single high-powered green LED (M530L2, Thorlabs, Newton, NJ, USA) with a 
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short-pass filter for fluorescence imaging of Cy3 (FFOl-529/24-25, Semrock Inc, 
Rochester NY, USA) is included for fluorescence excitation. These sources are combined 
using a 50:50 non-polarizing beamsplitter before entering the illumination optics. Since 
the light sources are LEDs, the illumination paths have been merged into a common 
Kohler configuration for even intensity across the FOV. In order to maintain a large FOV 
while providing a high NA collection, the imaging path consists of a 5x 0.5NA objective 
(1-MVX200, Olympus, Center Valley, PA, USA) coupled with the corresponding tube 
lens (3-MVX200, Olympus, Center Valley, PA, USA) and a 0.63.X magnification adapter 
(MVX-210, Olympus, Center Valley, PA, USA). The resulting FOV is 2.5 mm x 3.4 mm 
with a 1" format camera sensor (Retiga 2000R, Qimaging, Surrey, BC, CA). For efficient 
switching of modalities, the custom 52 mm x 58 mm dichroic mirror (Di01-R532-52x58, 
Semrock Inc, Rochester, NY) and emission filter (FFOl-575115-25, Semrock Inc, 
Rochester, NY) for Cy3 are designed for quick removal and swapping with the 50:50 
non-polarizing beamsplitter required for IRIS imaging. 
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Figure 3.7: CaFE instrument design. (a) Schematic of the optical layout. For fluorescence, the second 
beamsplitter is swapped for a dichroic mirror and the emission filter is inserted. (b) Model of instrument 
with key components labeled. (c) Image of the constructed instrument. 
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3.3.2 High NA Reflectance Model 
The objective selected for sensitive fluorescence measurements has a high NA. As 
discussed in Section 2.4.2, the 211d generation IRIS analytical model accounts for the 
linewidth of light sources, but the paraxial approximation is still applied to simplify 
calculations. Adjusting the analytical model appropriately leads to an ASR analytical 
model. Additional complexity can be immediately seen as the reflectance of TE, Rs , and 
TM, RP, must now be calculated independently, see Equations 3.1 and 3.2. Since the 
LEDs are unpolarized, the contribution from each polarization can be considered equal, 
see Equation 3.3. 
( 1 (}) ( 1 (}) - j2kz (A,O)d rs,l2 ""' + rs,23 ""' e 12' 
Rs =I 1 (2 B) (2 B) - J2kz (;, ,e)d 
+ rs,l2 ' rs,23 ' e 
(3 .1) 
r (2 B) + r (2 B)e-12kz (},,O )d 
R =I p ,l 2 ' p,23 ' 12' 
P 1 + r (2 B)r (2 B)e-12kz (}, ,O)d 
p,l 2 ' p,23 ' 
(3.2) 
(3.3) 
The Fresnel coefficients and the wavenumbers for an angular illumination are: 
(3.4) 
(3.5) 
(3.6) 
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(3.7) 
(3.8) 
Where (}1, B2 , and (}3 are the propagation angles in air, Si02, and Si, respectively. 
These angles can be calculated using Snell's Law. 
The new analytical model greatly complicates the computational process. For the 
proposed instrument, the processing time will be greatly affected by the implementation 
of the ASR model. Determining the NA where the error from the paraxial approximation 
model exceeds tolerance governs if the ASR model or paraxial approximation model 
should be used. Monte Carlo simulations are conducted to estimate the IRIS error as a 
function of NA. As IRIS measurements relate the difference between the spot thickness 
(Si02 +biomass) and background thickness (Si02) to extract the amount of mass bound, 
Monte Carlo simulations were conducted to emulate a 1 nm Si02 spot. For an increasing 
NA, the reflectance values of a 500 nm Si02 layer and a 501 nm Si02 layer were 
generated, noise approximating the system noise (shot noise, readout noise, and dark 
current noise) was added, and then the noisy data was fitted with the ASR and paraxial 
approximation models. The metric of evaluation selected is the percent error for the 1nm 
Si02 growth. 
In more detail, the Monte Carlo simulations: (1) generate the reflectivity of a Si02/Si 
chip for a given NA, LED spectral profile, and the two Si02 thicknesses. The LEDs are 
assumed to have Gaussian spectra with bandwidths approximating the VHL ACULEDs 
from Excelitas technologies. (2) The system noise (shot noise, readout noise, and dark 
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noise) is calculated for each simulation and added. Note, the quantity of shot noise added 
is randomized for each LED and follows a Poisson distribution. (3) The analytical model 
(ASR or paraxial approximation) is applied to the noisy data using the Levenberg-
Marquardt algorithm. The result yields the calculated optical thickness for the noisy data. 
(4) The two optical thicknesses are subtracted to determine the relative Si02 thickness 
change. (5) The percent error between the simulated and the actual Si02 thickness change 
is determined. 
As shown in Figure 3.8, the paraxial approximation model becomes erroneous at 
higher NA while the ASR model stays consistent. Therefore, to accommodate high NA 
systems, such as sensitive fluorescence imaging platforms, the more complex ASR model 
should be utilized for accurate and precise measurement of the probe density. 
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Figure 3.8: Monte Carlo simulations ofiRIS accuracy for a 1 nm thickness change (~ 1 ng/mm2 of protein) 
while increasing NA. (a) The paraxial approximation model becomes more erroneous at higher NA leading 
to a model breakdown. (b) However, the ASR model shows a significantly reduced and constant error. The 
vertical errors bars are ±1 standard deviation for N=lOO. 
3.3.3 Validation Assay Procedure 
Instrument validation is performed using a ~-lactoglobulin assay [ 16]. A direct label-
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free comparison between the IRIS platform and the CaFE reader is completed to ensure 
an accurate measurement of probe immobilization with the ASR model. In addition, the 
calibration capabilities of the CaFE platform are compared to the IRIS and GenePix 
4000B systems through an anti-~-lactoglobulin/~-lactoglobulin fluorescence sandwich 
assay using Cy3-label-secondary antibodies. The anti-~-lactoglobulin1~-lactoglobulin 
system was selected for its well-established spotting protocols and reliable spotting 
morphologies. 
A traditional sandwich assay using an anti-~-lactoglobulin1~-lactoglobulin system is 
conducted to model a variety of different antigen/ligand interactions. Ten replicates of 
anti-~-lactoglobulin of varying concentrations (0.015, 0.03, 0.063, 0.125, 0.25, and 1 
mg/ml) are spotted onto 4 ONC chips and 4 CLC chips. After overnight humid chamber 
incubation, all slides are washed 3 times with 1X PBS with Tween 20 (PBST), 3 times 
with 1X PBS, and 2 times with DI water for 4 minutes each, washed with water, and 
dried with a stream of argon gas. At this point, the immobilized probe density is 
measured using the IRIS platform and the label-free modality of the calibrated 
fluorescence reader. The slides are blocked with 50 mM ethanolamine in TRIS/HCl 1 M 
pH 9 for 45 minutes and incubated with 10 11g/mL of ~-lactoglobulin in PBS for 2 hours. 
Next, the slides are washed with IX PBST for 10 minutes, rinsed with water, dried with 
Argon gas, and incubated with 1 11g/mL of Cy3 labeled secondary antibody against ~­
lactoglobulin in 1% weight/volume BSA in PBS for 1 hour. Finally, the slides are washed 
with PBS for 10 minutes, rinsed with water, and dried with Argon before the fluorescence 
signal is measured with the GenePix 4000B scanner and the calibrated fluorescence 
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reader. 
Fluorescence evaluation with the GenePix4000B was performed using 90% PMT 
gain and 90% laser power for the maximum fluorescence signal without saturation. 
Fluorescence evaluation with the CaFE reader was performed using a 60 second exposure 
time at maximum LED power. The mean fluorescence intensity of each concentration 
was normalized by the maximum detected fluorescence signal for each calibration 
approach and then plotted against the corresponding immobilized surface probe density. 
3.3.4 Results and Discussion 
The CaFE instrument integrates the IRIS technique and fluorescence imaging to 
calibrate the fluorescence response to the probe immobilization of a microarray. Figure 
3.9 shows the label-free accuracy of the integrated reader against the IRIS platform. The 
integrated platform results agree with the IRIS system for both chip configurations. Thus, 
the conclusion can be drawn that the ASR model for high NA imaging offers equal 
accuracy and sensitivity to the IRIS platform. 
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Figure 3.9: Comparison of the IRIS platform and the calibrated fluorescence reader's label-free modality. 
Diminishing concentrations of probe were spotted onto 4 slides for ONC and 4 slides for CLC. The 
resultant average and standard deviation of the 10 replicate spots at each spotted concentration on both 
calibration slide types are shown here for both instruments. An R2 value of>0.995 in both cases 
exemplifies the validity of the ASR model for high NA IRIS measurements. Error bars are ±1 standard 
deviation for N= 10. 
With the new high NA model authenticated, the calibration performance of the ONC 
and CLC designs can be evaluated for the integrated platform. Figure 3.10a shows a 
correlation of 0.95 for the ONC and 0.93 for CLC. These results illustrate the CaFE 
platform's capability to calibrate the microarray accurately. Comparing the calibration · 
response of the integrated system to the optimized IRIS and Gene Pix 4000B combination 
shows almost identical normalized responses (Figure 3.10b). The near-complete overlap 
of the integrated platform calibration and the IRISIGeilePix calibration proves the 
integrated system is able to operate with comparable IRIS and fluorescence sensitivities 
for accurate assay calibration. 
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Figure 3.10: Validation of the integrated system calibration. (a) The fluorescence signal shows a highly 
linear relationship to the measured probe density for both the ONC and CLC configurations on the 
calibrated fluorescence reader. (b) Comparing the integrated reader response to the IRIS and GenePix 
4000B instruments shows a close relationship in calibration response. In both plots, the fluorescence is 
normalized by the maximum measured signal. 
3.4 Conclusion 
The performance of a microarray can be affected by the array geometry, probe 
density, spot morphology, background signal, probe specificity, and detection sensitivity. 
Through careful design of the array layout, surface chemistry, antibody selection, and the 
detection modality, most of these sources of variation are controlled [91 ]-[93]. Probe 
immobilization, however, inherently fluctuates because of the complex and delicate 
relationship between protein biochemistry and immobilization/spotting conditions. 
An integrated CaFE reader has been designed and validated to correct for variation in 
the probe immobilization. This reader incorporates IRIS and wide-field fluorescence 
imaging measurements to calibrate the fluorescence response of the assay to the probe 
density. The ASR analytical model for high NA IRIS measurements has been validated 
through direct comparison of the integrated reader and IRIS system. A sandwich assay 
was conducted by spotting anti-P-lactoglobulin, incubating P-lactoglobulin, and then 
incubating a Cy3-labeled-secondary antibody against P-lactoglobulin to verify the 
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fluorescence sensitivity and linearity of the calibrated response. The resulting calibrated 
curve shows a strong correlation among all the chips. Additionally, the CaFE reader 
showed equal calibration performance to the IRIS and GenePix 4000B readers. These 
experiments verify both the label-free and fluorescence detection capabilities as well as 
illustrate the capability to calibrate an assay with a single, integrated platform. 
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Chapter 4 
DIGITAL MICROARRAY DETECTION 
Clinical protein microarray applications have been hindered by repeatability and 
sensitivity issues due to bioreceptor immobilization variability and non-specific 
molecular binding. The CaFE technique prevailed over these problems with a hybrid 
label and label-free approach [2]. In the CaFE technique, wide-field fluorescence 
detection was utilized to specifically detect the biomarkers. Although labeled techniques 
have a distinct advantage over label-free techniques in detection specificity, designing the 
labels to not affect the protein's functionality and to minimize cross-reactivity is 
cumbersome for a multiplexed assay. Furthermore, labeled assays require additional 
incubation steps that increase the assay time. The development of a label-free modality 
capable of specific molecular detection is essential for highly multiplexed and/or rapid 
clinical assays. 
This chapter will detail the theory and design of a single particle detection platform, 
called SP-IRIS, capable of discriminating between specific and non-specific binding. 
Utilizing interferometry and a high resolution microscope, the SP-IRIS method images 
the diffraction pattern of biological nanoparticles down to 60 nm in diameter directly 
[67]. Analysis of the imaged nanoparticle response has been shown to yield information 
about the particle size that can then be used to identify specific binding [66] , [67], [94]. 
This digital detection of nanoparticles coupled with sizing verification has shown to 
dramatically improve the sensor's detection capabilities in clinical samples [6]. To 
eliminate user error and disseminate this technology to clinical laboratories for further 
73 
testing, an automated SP-IRIS detection platform has been built [95]. 
4.1 SP-IRIS Detection Principle 
The detection of single biological particles, like whole viruses, using light scattering 
IS challenging. Biological materials, whether cellular or a molecular, have a small 
scattering cross-section when they are in the presence of scattered light because of the 
small refractive index differences when compared to the surrounding medium. As 
described by Mie [96], the electric field scattered from a nanoparticle in free-space, Es, 
is proportional to the induced dipole moment, p , that can be described by the 
polarizability of the particle, a, and the incident electric field, Ei T97]. 
Es ex: p = aEi, (4.1) 
For particles much smaller than the wavelength of light, the scattered signal can be 
approximated by Rayleigh scattering theory. In this case, the polarizability scales with a 
cubic dependence on the radius, r . 
(4.2) 
Where E P , . Em, and Em .are the permittivity of the particle, surrounding medium, and 
vacuum, respectively. This cubic dependence indicates that techniques that measure the 
scattering intensity ofthe nanoparticle have a signal that scales with the particle's radius 
to the sixth power, see Equation 4.3. (In other words, the scattered intensity from a 1 1-lm 
bacterium is 1 million times greater than a 100 nm viral particle.) This rapidly 
diminishing response for biological nanoparticles is consumed by the system noise. 
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(4.3) 
SP-IRIS utilizes a common path interferometer to Image and discriminate single 
nanoparticles. Introducing a spacer layer and mirror below the particle introduces an 
interference effect in the far-field signal, see Equation 4.4. The resulting detected 
intensity is described by the addition_ of the scattering and reflected field, E,.. In this 
configuration, the far-field intensity approximately scales to the radius cubed for 
enhanced visibility of nanoparticles, see Figure 4.1a. The enhanced nanoparticle contrast 
enables the detection of particles down to 60 run; see Figure 4.1 b, in a large FOV (240 
)liD x 180 )liD). Additionally, since the signal has an approximate cubic dependence on 
the radius, nanoparticle can be classified by size (67], [98]. 
(4.4) 
Where 8 is the relative phase between the reflected and scattered fields. In this case, 
I Es 12 is equivalent to the previous case and will scale to the sixth power, 1 E,. 12 
contributes constant background intensity and the interference term forms the dominant 
optical response of the nanoparticle. 
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Figure 4.1: (a) Ratio of the particle contrast between free~space scattering and scattering on a 100 nm 
Si02/Si surface for polystyrene beads. As expected, the interferometric response generates a much greater 
signal for small particles. (b) Calculated d~focus response of a 60 nm polystyrene bead. The red line 
represents the noise floor. 
A common path interferometer is selected over double path configurations that are 
common to holography for robustness when using LEDs. For instance, when performing 
interferometry with a Michelson interferometer, the incident beam is split into two arms, 
a detection and reference arm, as shown in Figure 4.2. Both arms propagate an equal 
distance, 2L, but the . detector arm is passed through an unknown sample. Upon 
recombining, the beams interfere and the resulting intensity on the detector is 
proportional to the phase delay induced on the detection arm by the unknown sample. 
Any vibration on one or both of the arms will result in a spatial displacement of the beam. 
For a spatially coherent source, like a laser or an incoherent source passed through a 
pinhole, the spatial displacement does not affect the interference of the beams; however, 
spatially incoherent sources, like LEDs, will have an unpredictable response. Therefore, 
the SP-IRIS technique employs a common path interferometer for a greater level of 
stability. 
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Figure 4.2: Michelson Interferometer. The input beam (source) is split into 2 arms. The split beams travel 
equal distance, reflect off a mirror, and recombine onto a detector. However, one arm is lagged by an 
unknown sample. The resulting interferometric signal is a function of the induced phase delay. 
The SP-IRIS optical path is a Kohler illumination path and a 4-fimaging system, see 
Figure 4.3a. The nanoparticles are detected by interfering the scattering from the 
nanoparticle (arm 1) with the reflection off the buried Si02/Si interface (arm 2), see 
Figure 4.3b. The sub-diffraction interference signal is relayed to the imager and produces 
an airy function, see Figure 4.3c and d. The contrast ofthese particles, peak value divided 
by the local background, is then extracted to determine the particle size. 
ceo 
(a) 
(d) 
Figure 4.3: SP-IRIS Detection Concept. (a) Optical schematic of the SP-IRIS platform. (b) The scattering 
from a nanoparticle is interfered with the reflection from a buried interface. (c) A cropped image showing 
the detection of 150 nm diameter polystyrene beads for 635 nm illumination. (d) Response of a particle 
from (c). This image is modified from [67]. 
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4.2 Automated Single Particle Platform 
The difficulty in using this technique is focusing. The imaged particle response is 
dependent on the relative phase between the reflections, the permittivity of the particle 
and surrounding environment, the incident wavelength, the collection NA, and the 
imaged focal plane. All of these parameters except the imaged focal plane are known and 
controlled. The phase difference is set by the Si02 layer thickness. The particle 
permittivity and surrounding environment permittivity are specific to the assay. The 
instrument design sets the incident wavelength and collection NA. Only the focal plane is 
a user-defined parameter. As shoWn in Figure 4.4, the range of defocus values where the 
nanoparticles (100 nm) are visible over the background is small (± 0.5 )..lm) and rapidly 
varying. For accurate and repeatable data, the user must be able to adjust the focus with 
an accuracy of± 50 nm. 
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Figure 4.4: Defocus profile of a 100 nm nanoparticle on a 100 nm Si02/Si chip. The background signal 
(horizontal red line) limits the visibility of the nanoparticle to a± 500 nm range. Additionally, the peak 
contrast extends over only a 100 nm range. These constraints complicate the data acquisition process. 
For this technology to move forward as a diagnostic platform, the dependence on the 
user's focusing skill must be removed. To this end, an automated and easy-to-use SP-
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IRIS platform has been designed, constructed, and tested, see Figure 4.5 . This standalone 
platform interfaces automated XYZ stages and a custom GUI with the SP-IRIS optical 
path to allow for automated acquisition and processing. Two complimentary focusing 
algorithms are implemented in tandem to achieve the ± 50 nm accuracy for robust 
nanoparticle detection. For validation, the detection capabilities of this automated 
prototype are compared against the manual benchtop system on a wild-type vesicular 
stomatitis virus (wtVSV) assay. 
(a) (b) (c) 
Figure 4.5: SP-IRIS prototype. (a) Image of the prototype. (b) Patterned chip loaded into the sample holder. 
The center square region is for spotting. (c) Image of an antibody spot on the prototype. 
4.2.1 Hardware Design 
In the following discussion, the components and materials of individual design 
elements (the sensor chip, the optics, the electronics, and the mechanics) are given. For 
each design component, the specific part numbers are provided. These components were 
selected to meet or exceed design requirements. 
Sensor Chip Design. For Si02/Si chips, a thickness of 100 nm has been selected to 
maximize the phase angle term [94] . Silicon chips with thin layers of Si02, fabricated by 
SVMI, Inc. (Santa Clara, CA, USA), were designed to be used with a reusable loading 
holder Figure 4.6. Fiduciary patterns enable the use of an automatic spot detection 
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algorithm, in addition to providing contrast for autofocusing algorithms. The dimensions 
of the chips are 10 mm x 10 mm x 0.5 mm, with a 2.3 mm x 2.3 mm active center region 
for spotting capture probes. Small, periodic etched squares (15 !liD x 15 !liD every 143 
!liD) in the capture probe area ensure that regions of high contrast are present in the field-
of-view for coarse focusing, independent of the precise location of each capture probe 
spot. 
Figure 4.6: Floor plan of an SP-IRIS chip. The active region in the center is used for biosensing. Additional 
fiduciary marks outside of the active region enable repeatable robotic spotting. 
Optical Design. The SP-IRIS technique is based on a top-illumination microscope 
scheme. The key parameters in the optical path design are the illumination wavelength, 
uniformity, NA, magnification, and camera pixel size. These parameters determine the 
accuracy of sizing, throughput, and minimum detection size of the system. 
In imaging systems, the uniformity of illumination is vital to obtain comparable 
performance across the sensor surface. For the SP-IRIS technique, improper illumination 
will affect the detection and sizing capabilities. In particular, because sizing is calculated 
via contrast of the central peak to near-neighbor background pixels, non-uniformity of the 
illumination will induce sizing ambiguity. As discussed in Section 2.2.2, for LEDs and 
filament sources, uniform illumination is achieved through Kohler illumination. 
Adjusting the NA offers a tradeoff between nanoparticle contrast and usable FOV. 
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The image of the nanoparticle is calculated from a forward model that is derived using 
the angular spectrum representation, where the nanoparticles are modeled as dipoles to 
determine the expected far-field signal of the virus [99]. To ensure reliable detection of 
the virus, an NA offering a SNR of at least 3 over the background noise was selected. 
Figure 4.7 shows the contrast response of a 100 nm virus (equivalent to H1N1) and the 
peak of the response as a function ofNA. 
Particle sizing in the SP-IRIS technique is performed by comparing the detected 
particle peak contrast to the predictive forward model. A potential source of error in this 
comparison is undersampling of the point spread function (PSF). If the PSF is ill-defined 
on the camera, the central peak of a nanoparticle's PSF could be blurred between 
multiple pixels leading to error in the contrast calculation. To guarantee proper imaging 
of the PSF, an oversampling rate of at least 3 pixels is recommended. In this case, the 
diffraction-limit resolution specified by the Rayleigh criterion is 400 nm. Therefore, an 
effective pixel size of 134 nm x 134 nm should be used. The prototype system meets this 
requirement with a 50x, 0.8 NA Nikon objective and the Grasshopper 2 GigE CCD 
camera (Point Grey Research, Inc., BC, Canada) with 2 x 2 binning. The resulting optical 
parameters are an effective pixel size of 138 nm x 138 nm and a total FOV of 168 J..lm 
x141 J..lm. 
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Figure 4.7: Theoretical response of a 100 nm virus with a varied NA. The dashed horizontal bar indicates 
an SNR of three above the background noise. The dotted vertical line indicates the selected NA, 0.8. 
Electrical Design. For rapid system development, an attempt was made to maximize 
the use of commercial off-the-shelf subcomponents. This included a Gigabit Wireless 
Router (AirStation HighPower N450 Gigabit Wireless Router, Buffalo Technology, 
Austin, TX, USA), an industrial serial RS232 to Ethernet Converter (BF-431, 
Gridconnect Inc., Naperville, IL, USA), a high-power LED (Golden Dragon LT W5 SM, 
OSRAM Opto Semiconductors), and a high-speed Gigabit CMOS Camera (GS2-GE-
50S5M-C, Point Grey Research, Richmond, BC, Canada). 
To integrate all these components together inside the SP-IRIS enclosure some custom 
electronics are needed to control the LEDs and generate the necessary supply voltages for 
all subcomponents from the single 24 V DC power supply. To save space, four 64 mm x 
64 mm, four-layer printed circuit boards are vertically stacked and connected through a 
26 pin cable. Each board serves a single purpose: high efficiency regulation of the 
necessary 12 and 5 V power supplies, constant current LED driving circuits (TL4242, 
Texas Instruments, Austin, TX, USA), Ethernet to UART interface, and a microcontroller 
(MSP430AFE221, Texas Instruments, Austin, TX, USA) to allow TCP/IP commands to 
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be issued to control the LEDs. 
By using a gigabit router for all communications to subcomponents, standard TCP/IP 
networking protocols were used over 10/100/1000 Mbit Ethernet with category-6 
unshielded twisted pair cables. This allows a single interface for communication with 
components and will enable a seamless transition to high-speed wireless interfaces 
(802.1ln) for control and interfacing. The system uses a peak power of 29 W during 
power-up and acquisition, and 23-24 W while idle. 
Mechanical Design. A FOV of 168 Jlm x 141 Jlm and a focus dependent particle 
sizing gives the potential for cross-dataset variability, as small differences in operator 
technique can result in significant divergence in particle counts. Designing an operator 
independent protocol is vital for POC devices. The mechanical design of the system 
solves the issue with rigidity and automation. 
The SP-IRIS prototype utilizes a 3-axis orthogonal stack of linear stages (VT-21, 
MICOS USA, Irvine, CA, USA) to enable the rapid scanning of samples. A removable 
chip holder secures the sensor in a repeatable location with a spring-loaded latch. The 
holder is then secured to the stage assembly via a series of alignment pins and magnetic 
retention features. Fine alignment adjustments are enabled via a pitch/yaw mechanism 
built into the stage assembly. 
All required optics, mechanics, and electronics are incorporated inside a robust and 
portable housing measuring 17 in x 11 in x 8 in. An aluminum base plate equipped with 
vibration dampening feet provides a stable mounting platform for all onboard 
components and doubles as a heat sink for the stage components. 
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4.2.2 Software Design 
The user interface of a POC diagnostic instrument must be easy to use. Ideally, an 
untrained operator with a high school degree or equivalent should be able to use the 
instrument with a simple set of instructions. Creating a user-friendly interface requires a 
high level of mechanical and software automation. Applying these criteria to a high-
resolution optical technique requires engineering in both image acquisition and image 
processing. In the analysis of microarray assays, the time to process each spotted 
condition becomes the determining factor behind measurement time. The following 
sections detail a user-friendly interface and the novel image processing algorithms to 
achieve acquisition times less than 1 min per spotted condition. 
Graphical User Interface. Incorporating a simple, easy-to-use, and readable user 
interface is pivotal in developing a tool for POC settings. In these environments, the 
target user cannot be required to have specialized training. With the algorithms discussed 
in the following sections, the SP-IRIS instrument is able to achieve a 5-click interface, as 
shown in Figure 4.8. This interface requires user interaction only for loading/unloading 
and basic array information. Once the user clicks acquire and analysis, the software 
precedes spot to spot acquiring data. The first spot of the array is located through the use 
of fiducial marks and subsequent spots are found through the user defined spot pitch. At 
each spot, the instrument executes the focus algorithms. Once focused, the number of 
viral particles detected is tallied and recorded in the table. During this time, the operator 
is available to continue other clinical operations and can return to reload the system once 
analysis has completed. 
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Figure 4.8: Graphical User Interface. The software shown here simplifies acquisition and analysis for 
untrained to minimally trained users. The user defines the array geometry (array size and spot pitch), loads 
the sensor chip, and then clicks once for acquisition and analysis. When the instrument finishes, results are 
reported in the table and saved into a spreadsheet. Additional functionalities are included in other tabs for 
advanced users but not required for typical operation. 
Particle Detection. Robust, rapid, and automated particle detection 1s an enabling 
feature of an easy-to-use SP-IRIS interface. The detection of the sparse nanoparticle 
diffraction patterns in the image requires the implementation of several image processing 
techniques. To start, an important observation is these nanoparticles are well localized 
and local extrema in the pixel space. A profile of a 100 nm viral nanoparticle is shown in 
Figure 4.9. Such features are the characteristic of an interest point in computer vision. 
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Interest point detection is a well-studied subject, and tools from the existing literature 
have been adapted for robust detection of the nanoparticles. Scale invariant feature 
transform (SIFT) has been proven to be one of the most robust interest point detection 
methods and has been used to automate detection in this instrument [100] . 
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Figure 4.9: Simulated response of a 100 nm spherical viral particle in the SP-IRIS system. 
In SP-IRIS images, given the particle type of interest and other experimental 
variables, the forward model is computed and the expected normalized peak response of 
the particles of interest is known. For example, if one aims to image 100 nm viral 
nanoparticles, the expected normalized peak value would be around 1.06. This 
information is used to eliminate strong interest points that are related to salts and large 
nonspecifically bound particles. In order to detect strong interest points, the ratio of the 
maximum to minimum value of a pixel in its local neighborhood is computed and 
thresholding is used to find regions with high intensity differences. The resulting binary 
image is named as the anomaly map. Figure 4.10 shows the detection and elimination of 
anomaly region. Note that for sizable anomalous structures, the pixels toward the center 
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of the large structures do not have a high intensity difference. In order to overcome this, a 
morphological close operation is used to fill such gaps in sizable structures. 
(a) (b) 
Figure 4.10: Anomaly Filtering. (a) Detected anomaly map of nonspecific structures. (b) Using the anomaly 
map to discard particles within those regions, the nanoparticles of interest (green circles) are accurately 
identified. 
Closed-Loop Focusing. The automation of optical devices requires the use of robust 
autofocusing. For POC devices, a robust, precise, and real-time algorithm is imperative to 
minimize experimental time and prevent erroneous results. Choosing the correct passive 
autofocusing algorithm weighs heavily on the imaging modality and the target object 
[101 ]. For some applications, the sample alignment conditions are loose. However, in the 
case of SP-IRIS, focusing is critical as the response of the nanoparticle rapidly peaks. The 
challenge of a rapid focusing algorithm is compounded by two issues: 1) a narrow 
detectable window where the nanoparticle contrast is above the background and 2) the 
optimal focal plane of the nanoparticles does not coincide with the sensor surface. To 
approach the autofocusing for the SP-IRIS technique in a robust, rapid manner, two 
complementary algorithms have been implemented. 
When the sensor is loaded, the removable chip holder latches into the stage assembly. 
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Since the nanoparticle detection window overlaps with the sensor surface, the coarse 
focusing algorithm is executed to bring the imaging plane to the sensor surface by 
focusing on the 15 !lm square fiduciary marks within the FOV. The stages are swept 30 
!lm acquiring an image every micrometer. A fast Fourier transform is applied to the stack 
of the images followed by a high-pass filter. The remaining high frequencies are 
summed. The most in-focus plane corresponds to the maximum sum. With the stages 
now within 2 !lm of the sensor surface focal plane, the algorithm is reiterated over 2 !lm 
with 100 nm steps. The resulting in-focus plane is somewhere within the nanoparticle 
detection window. 
For repeatable s1zmg, a nanoparticle detection feedback algorithm is executed to 
locate the nanoparticle peak contrast plane. This algorithm swings from -300 to + 300 nm 
of the current location by 100 nm increments acquiring images. Each image is then · 
processed to detect and size the detected nanoparticles. The optimal focal plane is 
determined by maximizing the number of particles within the desired particle size range. 
This algorithm in combination with the coarse focus requires less than 90 seconds, as 
shown in Figure 4.11. 
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Figure 4.11 : SP-IRIS focusing procedure. The coarse focusing algorithm locates the correct plane using the 
on-chip reference region. This method is accurate within 1 f.liD. A nanoparticle feedback algorithm is then 
executed to maximize the number of particle detected. 
These algorithms have shown high repeatability in clean data. Clean data is defmed as 
spots without large debris. Nevertheless, nonspecific binding and salt deposits occur in 
non-ideal laboratory settings. Anticipating the situations where nonspecific binding will 
bias the high-pass filter autofocus algorithm to the wrong starting plane, the algorithm 
also performs shifting window detection. If the optimal plane is determined to be at either 
extreme of the current window, the focal planes being analyzed will be shifted. The new 
window of focal planes will be acquired and processed. Shifting the focal plane increases 
the robustness of the autofocusing but at a cost of time. To prevent runaway situations, 
the number of iterations is limited to four per spot giving a total analysis range of 2.2 11m 
to the nanoparticle detection feedback algorithm. 
4.2.3 Platform Characterization 
Clinical diagnostic tests are rarely performed with simple sample solutions. Typically, 
biomarker analytes are vastly outnumbered by endogenous proteins and macromolecules 
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found in unprocessed patient samples. Ensuring that the diagnostic assay can specifically 
and sensitively detect the target within a complex solution is imperative. The presence of 
other macromolecules can lead to nonspecific binding that decreases the test confidence. 
A proof-of-concept experiment showing specific detection of wtVSV spiked in 100% 
fetal bovine serum (FBS) was performed. To ensure that the constructed prototype 
operates in a comparable capacity to our laboratory system, this experiment is also used 
as a benchmark. 
An antibody against the wtVSV surface glycoprotein (8G5 monoclonal antibody) and 
a negative control monoclonal antibody (specific for the Marburg virus glycoprotein) 
were arrayed onto the sensor that is functionalized with the copoly (DMA-NAS-MAPS) 
(Lucidant Polymers, Sunnyvale, CA, USA). The array was printed with the 
sciFlexarrayer S3 spotter (Scienion AG, Berlin, Germany) and consisted of five replicates 
of each antibody. After an overnight incubation, the surface was first treated with 50-mM 
ethanolamine (pH 8), then washed with PBS containing 0.1% tween-20 to remove any 
remaining unbound material followed by blocking for 1 h in a petri dish with 1% BSA 
with PBS. Finally, the sensors were thoroughly rinsed in DI water to remove salt. The 
images of the resulting antibody spots were acquired on both the prototype and laboratory 
platforms to determine the number of pre-incubation bound particles. Next, the sensor 
was incubated in another petri dish with undiluted FBS spiked with 5 x 105 plaque-
forming units per milliliter (PFU/mL) of wtVSV for 2 h. Following the incubation, the 
sensor was washed with PBS and rinsed quickly in DI water. Finally, post-incubation 
images of the spotted array were acquired. Figure 4.12 shows the specific detection of 
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100 to 140 nm diameter particles in the post-incubation images of SP-IRJS prototype. 
wtVSV is rod-like; however, when imaging with non-polarized light, the average 
polarizability that is equivalent to a spherical particle with a 110 nm diameter is ·observed 
[66], [94]. 
The comparison of the two platforms was conducted via the detected density of the 
wtVSV particles on both the wtVSV -specific and Marburg-specific antibody spots. 
Figure 4.13 demonstrates that the prototype is able to detect virus particles trapped on the 
wtVSV -recognizing antibody with little to no binding on the non-specific spot. An equal 
density between the platforms illustrates no loss in sensitivity. 
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Figure 4.12: Specific virus capture and detection. The panels show detection ofwtVSV (circled in green) 
for 0 and 5xl 05 PFU/ml concentrations for a 2hr incubation in a cropped area of 65 11m x 65 11m. 
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Figure 4.13 : Benchmark comparison for 5xl05 PFU/mL ofwtVSV. Identical areas of the wtVSV antibody 
and controls spots were analyzed on the prototype and laboratory SP-IRJS platforms. The number of 
particles detected between 90 and 140 nm were tallied. The mean and standard deviation for each condition 
were determined from particle counts on five replicate spots. 
4.3 Discussion and Conclusion 
The development of a clinical microarray platform necessitates the classification of 
specific and non-specific binding. Labeled techniques have shown to have a distinct 
advantage over label-free techniques in specificity, but multiplexed assay design is 
complicated by making sure the labels do not affect the functionality of the protein and 
minimizing cross-reactivity. The additional incubation steps that increase the assay time 
are also undesired. 
The SP-IRIS detection technique has been established as a label-free technique with 
high specificity. This technique is capable of detecting the diffraction pattern of single 
particles in a large FOV. Through analysis of the diffraction pattern's contrast, 
information on the particle's size can be extracted. With a priori knowledge of the target 
molecule's size, the SP-IRIS method can perform specific detection via particle size 
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filtering. Nevertheless, performing accurate nanoparticle s1zmg IS an operationally 
complex process as a result of the narrow, rapidly varying nanoparticle response. 
Instead of requiring a highly trained operator, a prototype has been designed to 
automate data acquisition and processing. The automation of the acquisition and 
processing enables minimally trained or untrained user operation. The custom GUI has a 
simple 4-button interface and tabular readout for ease of use. This platform has two 
complementary focusing algorithms to achieve a precise focusing algorithm with 100 nm 
accuracy. The performance of this automated system was validated against the laboratory 
platform for wtVSV detection at a clinically relevant level (5 x 105 PFU/ml) in undiluted 
FBS. 
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Chapter 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
Illnesses occur when the balance of biological molecules in living organisms is 
disrupted by perturbation in functionality or concentration of biomarkers. Although many 
tools exist for profiling DNA biomarkers, protein diagnostic tools lack sensitivity and/or 
repeatability for clinical samples. These techniques are hindered by fluctuations in 
bioreceptor immobilization between protein rnicroarrays and the greater level of non-
specific binding. 
This dissertation detailed the development of three practical platforms (IRIS, CaFE, 
and SP-IRIS) for high-throughput, sensitive, and repeatable protein rnicroarray detection. 
The label-free IRIS platform exploited interferometric spectral reflectance imaging to 
quantify bioreceptor accumulation on the Si02/Si chip surface. The implementation of 
LEDs, an on-chip intensity monitoring region, and a linewidth analytical model in the 2nd 
generation IRIS instrument reduced the component costs to under $1 Ok and the footprint 
to 9 in x 18 in x 4 in while maintaining the capacity to measure 1 OOOs of proteins 
simultaneously with an intrinsic mass detection limit of 4 pg/rnrn2. 
The CaFE platform integrated IRIS with wide-field fluorescence imaging to quantify 
probe immobilization and discriminate between specific from non-specific binding. Two 
chip designs, ONC and CLC, have been designed for sensitive IRIS measurements as 
well as broadband and selective fluorescence enhancement, respectively. An integrated 
CaFE platform has been designed for all-inclusive measurements. The rationale for 
integrating the two teclmologies has been laid out and, since fluorescence requires a high 
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NA imaging system for sensitive measurements, an ASR analytical model has been 
developed for high NA IRIS imaging. The CaFE platform's performance has been 
verified via a direct comparison with the IRIS and Genepix 4000B readers. 
The SP-IRIS methodology offers a label-free method to distinguish between specific 
and non-specific binding. Labeled assays require careful development to prevent the 
fluorophore from altering the protein functionality in addition to extra time and reagents. 
For a simpler and faster assay while maintain a high level of sensitivity and specificity, 
the SP-IRIS detects single nanoparticles on an interferometric surface and sizes the 
nanoparticles for filtering. An automated SP-IRIS platform has been designed to reduce 
operational complexity and remove user error. A custom GUI which controls the stages, 
camera, and LED, streamlines the user interaction to loading the chip, defining the 
microarray geometry, and clicking run. 
5.1 Acceleration of SP-IRIS Focusing Algorithm 
The SP-IRIS automated prototype is the first step toward a specific label-free 
technology for reliable assay detection. An advantage of this platform is the specificity 
arising from the analysis of the nanoparticle signal. Currently, the prototype can acquire 
and process a spot in under 2 minutes, see Table 5.1. This time was achieved after 
optimizing each algorithmic step for speed. A 2-minute per condition acquisition and 
processing time is only practical for assays up to 30 conditions (1 hour acquisition time). 
For higher throughput arrays, the acquisition time must be quicker. With each individual 
algorithm optimized for fast acquisition, random access memory (RAM) disk and region 
of interest (ROI) imaging methods were explored for further improvement. 
95 
• 
Table 5.1 : SP-IRIS software timeline. The times listed below are the average when the algorithms are 
optimized for speed. *This time is an estimate. **Each image is full FOV. 
Process Description Automated? Time to Total time 
(YIN) complete (s) (s) 
Power on Instrument Initialization y 30 30 
start-up test 
Load assay · User defmes assay geometry N 20* 50 
information 
Load SP-IRIS User places chip on sample holder and N 30* 80 
chip loads 
Focus on chip Locate chip surface y 60 120 
surface 
Locate spot Determines chip lateral offset y 20 140 
array Moves to first assay spot 
Spot Focusing Coarse & Fine focus y 139 ± 27** 279 ± 27 
Repeated for every spot 
A RAM disk is a block of RAM that is treated as a disk drive for faster data 
read/write times. RAM access times, in general, are orders ofmagnitude faster than hard 
drive access times. Since the camera images are large, applying this technology may 
decrease the time required to load the images and process the data. Further 
experimentation revealed no measureable benefit from RAM disk. 
ROI imaging, on the other hand, dropped the focusing 43.8% (79.3 ± 14.3 s). The fine 
focusing algorithm was the only process to benefit from imaging a smaller FOV because 
of the CCD camera selected. Typically, with less information to read out per frame, a 
camera can achieve a faster frame rate. The faster frame rate would have benefited all of 
the focusing algorithms. However, the selected camera on the prototype, the Point Grey 
Grasshopper 2, is an exception. Therefore, the benefit from ROI imaging is seen only in 
image processing during the nanopatiicle feedback focusing. 
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The downside to ROI imaging is the reduction in the number of particles in the FOV 
for the feedback algorithm. For acclirate focusing of the sample, at least 30 nanoparticles 
must be present in the image. In biological experiments, it is not feasible to assume this 
kind of coverage on every spot especially since control spots should be clean. As an 
alternative, reference particles (RPs), 180 nm diameter polystyrene beads, were co-
spotted onto the chip surface with the bioreceptors. These particles provide the needed 
surface coverage for ROI focusing without inhibiting detection, Figure 5.1 
Figure 5.1: RP coverage experiment. Multiple concentrations of RPs were spotted onto the surface to 
determine the necessary spotting concentration to achieve the required surface coverage. Afterwards, VSV 
was incubated onto the surface to make certain the RPs do not inhibit the detection of the target molecules. 
In conclusion, the first iteration of the SP-IRIS focusing algorithm laid the 
groundwork for future designs. The current 2-minute per condition acquisition time, 
although automation, is not sufficient for large assays. Two methods were explored to 
decrease the acquisition time. The first method, RAM disk, showed no improvement and, 
thus, eliminated the read/write times of the hard drive as the limiting factor. The second 
method, ROI imaging, improved the spot focusing time 43.8%. Further investigation into 
these gains brought to light a flaw in camera selection. The reduction in time came 
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exclusively from image processing. Image acquisition showed no change contrary to 
expectations. Therefore, ROI imaging would have provided even greater improvement 
for a difference camera. Finally, the implementation of RPs to guarantee robust focusing 
in the abbreviated FOV was discussed. A viral assay was performed to determine the 
needed spotting concentration, 1011 particles/mL, and verify the RPs do not affect virus 
detection. 
5.2 Accurate Nanoparticle Sizing 
Although the SP-IRIS platform has been demonstrated to perform accurate sizing of 
polystyrene beads (~2% error from the nominal mean report by the manufacturer [67]), 
further experimentation has shown a sizing dependence on the Si02 layer thickness, see 
Figure 5.2. The dependence of the observed nanoparticle contrast on the Si02 thickness 
does not affect manual experiments as the user can adjust the data processing algorithm 
appropriately. However, since the accuracy and robustness of automated focusing relies 
heavily on nanoparticle sizing, either the Si02 thickness must be measured then 
referenced with a multi-dimensional sizing algorithm or sample fabrication must have 
less than 1% variation. As a stringent manufacturing process will significantly increase 
chip fabrication costs, the effect of Si02 on the particle sizing should be modeled and a 
multi-dimensional sizing curve should be used. 
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Figure 5.2: SP-IRIS Nanoparticle Sizing Dependence on Si02 thickness. Two size populations of 
polystyrene beads (110 nrn and 173 nrn diameter) were spotted with 4 replicates onto various Si02 
thicknesses. The average and standard deviation of each replicate spot for both sizes is shown. A SiOT 
dependent particle contrast is observed. 
5.3 Calibrated Single Particle Detection Platform 
The design and fabrication of an integrated IRIS and SP-IRIS platform, called 
calibrated single particle (CaSP), would enable same platform calibration of the particle 
detection signal. The CaFE platform illustrated the relationship between fluorescence 
signal and the immobilized probe density. This relationship is not confined to 
fluorescence detection as a varying probe density affects the binding capacity of the spot 
[6]. Additionally, as discussed in Section 5.2, the Si02 thickness must be quantified for 
accurate nanoparticle sizing. 
Many parallels can be drawn between the CaFE and CaSP platforms. The 
illumination path of both SP-IRIS and IRIS technologies can be combined into a single 
Kohler illumination. Unlike fluorescence, SP-IRIS does not require a high-powered LED; 
however, the slight offset of each LED alters the illumination profile at 0.8 NA resulting 
in perturbation of the nanoparticle signal. Therefore, there must be two illumination 
sources which are combined using a 50:50 non-polarizing beamsplitter. In addition to 
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separate light sources, mounting two objectives on a turret is recommended for imaging. 
At high NA, multiple spectral sources become problematic because of the small depth of 
focus and chromatic aberration in the objective. However, if a common objective is 
highly desired, a focusing feedback system with an algorithmic or optical, like the Nikon 
perfect focus system, could be developed. A preliminary design of the CaSP system is 
shown in Figure 5.3. 
Figure 5.3: CaSP Platform Preliminary Design. A 50:50 beamsplitter couples the two illumination sources 
into a Kohler illumination system. An objective turret allows for switching between the SP-IRIS high 
magnification, hjgb NA objective and the IRIS low magnification, low NA objective. A motorized stage is 
used for focusing and chip translation. The imaging path is a 4f system with objective and tube lens. 
5.4 Point-of-care Diagnostics 
The efforts in designing compact, low-cost, easy-to-use platforms have opened up 
new applications for this technology. One particular market of interest is point-of-care 
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(POC) diagnostics. The POC diagnostic device market - devices which operate outside of 
a laboratory with minimal to no user-training- is one of the fastest growing sectors of the 
medical industry [102] . The rapid market growth in this sector as compared to traditional 
diagnostic tests is attributed to the paradigm shift toward targeted early disease detection, 
therapy, and sample-to-answer automation [ 103]. For time critical situations, 
commercially available rapid diagnostic tests take the form of lateral flow immunoassays, 
which suffer from low sensitivity [104]. The lack of a sensitive and specific rapid test in 
the primary care setting requires clinical procedures to include a second confirmatory test 
conducted in a laboratory causing delays in diagnosis, prolonged recovery, and an 
increased chance of disease transmission [105]. The development of a compact system 
capable of laboratory quality measurement would represent an invaluable tool in the fight 
against diseases [ 1 06]. 
The challenges in POC tests are achieving the correct level of operational complexity 
and safety [ 1 07]. Ranging from the hospital staff performing in-patient testing to the lay 
person doing self-testing, the first task for POC applications is identifying the target 
environment and user. Once the target tier is known, test-specific criteria must be 
identified (e.g. platform portability, power consumption, platform costs, operational 
complexity, disposable costs, disposable storage & shelf-life, assay reagents, and 
acceptable assay false negative and positive rates). 
5.4.1 2"d Generation CaFE Design 
The 1st generation CaFE platfomi outlined the design criteria of a dual IRIS and wide-
field fluorescence reader. Further engineering of the platform can follow two diverging 
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paths: (1) a standalone platform for an automated all-in-one sample-to-answer reader or 
(2) a modular unit for existing fluorescence readers. 
The development of a standalone platform for complete sample-to-answer 
measurements would enable POC tests. In POC applications, operational simplicity and 
operator safety are crucial. The patient sample must be isolated from the user for safety 
and to prevent contamination. The standalone platform will require the implementation of 
an automated XYZ platform for focusing and indexing, a microfluidic cartridge, and 
fluidic controls to automate the assay. Although these items are not trivial, they have 
been addressed for similar technologies [14], [95]. 
The modular unit for existing fluorescence readers would escalate the value of this 
technique to other researchers in the field. The main difference between the CaFE 
platform and the typical wide-field fluorescence microscope is the light source. Wide-
field fluorescence microscopes typically use one of four types of light sources: a xenon 
arc lamp, a mercury-vapor lamp, a high-power LED, or a supercontinuum source. All of 
these sources require Kohler illumination or a similar optical path. Therefore, an 
illumination housing which unifies the fluorescence and the IRIS sources onto the same 
optical path would allow for the transition from a fluorescence reader to a calibrated 
fluorescence reader. 
5.4.2 SP-IRIS for Point-of-Care Diagnostics 
The efforts in designing an automated acquisition and processing instrument have 
enabled SP-IRIS to approach a new market, POC diagnostics. Although the SP-IRIS 
prototype provides automated operation, further reduction can be achieved in the power 
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consumption, footprint, complexity, and cost. The improvements will be seen by 
incorporating specialized components. 
The current prototype is controlled by a laptop, communicates to the component over 
Ethernet via a router, and uses a scientific CCD camera for acquisition. The footprint of 
the platform is 17 in x 11 in x 8 in. Instead of having these separate components, a 
custom embedded system could be designed. 
As a proof-of-concept, a manual SP-IRIS instrument has been designed wjth priority 
given to cost and footprint, shown in Figure 5.4. The new platform implements a smart 
phone (Nexus S, Samsung, Seoul, KR) in lieu of a camera and laptop. This redesign 
decreases the footprint to 15 in x 6 in x 4 in and the cost to under $4k. A custom software 
application has been written by Konrad Szupinski on the Android 2.3 "Gingerbread" 
operating system to control the LEDs via the headphone port and the camera. 
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(a) General Layout (b) Alignment Mechanisms 
Sample 
(c) 
Figure 5.4: Design and construct of the mobile SP-IRIS platform. (a) Side schematic of the smart phone 
platform. The illumination path is in a Kohler configuration. A 4-f imaging configuration projects the 
image onto the smart phone camera sensor. (b) Multiple mechanisms have been implemented for initial fine 
alignment of the system. (c) An image of the constructed mobile SP-IRIS platform. 
The detection capability of this platform was tested using a VSV chip and a 20x 
0.46NA objective. As shown in Figure 5.5a, the smart platform was able to resolve many 
diffraction limited particles and salt clusters; however, the image is out-of-focus. 
Comparing the particle locations between the smati phone system and the benchtop 
system, Figure 5.5b, many of the diffraction-limited particles are seen to match up. 
Before conclusive evidence can be obtained on the smart phone system, two design 
changes are needed. First, the mechanical vibration in this system prevents averaging 
more than 10 frames, an SNR of approximately 230. As shown in Figure 5.6, an SNR of 
400, approximately 30 images for the Nexus S, is needed for accurate particle sizing. The 
source of the vibration is the smart phone. Anchored to the system by only 4 cage rods, 
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the smart phone is susceptible to shaking. Second, the smart phone preview function does 
not have zoom capability preventing accurate manual focusing. Either new software must 
be written to enable zooming while previewing or an auto-focusing system should be 
integrated into the platform. 
(a) (b) 
Figure 5.5: Mobile SP-IRIS image. (a) After manually focusing, an image was taken of a VSV chip on the 
smart phone system. Although the image is out-of-focus preventing verification, this image shows the 
detection of large salt chucks as well as diffraction-limited particles believed to be virus. (b) An image 
from the benchtop system of the same spot. Many of the same particles are seen in both images. However, 
further alignment is testing is needed for conclusive evidence. 
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Figure 5.6: SNR analysis of SP-IRIS detection. First order monte carlo simulations were performed to 
estimate the error in the detected nanoparticle contrast signal for a given image SNR. For these simulations, 
a system with a 2.2 J.lm square pixel (size of a smart phone camera), a 0.8NA SOx objective, and a 532 nm 
illumination source imaged a 100 nm polystyrene bead on a 100 nm Si02 layer. For accurate sizing, an 
SNR of at least 400 is recommended. 
In conclusion, the results from this system encourage further investigation into 
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developing a POC diagnostic test based on the SPIRIS method. The proof-of-concept 
platform demonstrates the viability of utilizing an embedded system for nanoparticle 
detection, but a direct comparison between the smart phone system and the benchtop 
platform cannot be conducted until the smart phone system's rigidity and the focusing 
issues are resolved. Addressing these issues in the next iteration system would enable the 
detection and sizing nanoparticle on an almost hand-held system. 
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Appendix A 
IRIS QUANTIFICATION EXPERIMENTAL PROCEDURE 
Summary. To determine the conversion factor between SiOz thickness change and 
mass accumulation, purified BSA suspended in milli-Q water was spotted onto the 
surface. After allowing the water to evaporate, the signal from a known mass was 
measured. 
Procedure. BSA was purified through dialysis, lyophilized, and re-dissolved in milli-
Q water at a concentration of 2 mg/ml. Then, the BSA was serially diluted in milli-Q 
water using high precision pipettes from Gilson (Middleton, WI). The solutions were 
spotted using a Scienion SciFlexarrayer S5 piezoelectric arrayer (Berlin, Germany) 
equipped with the sciDrop VOLUME software, a tool to measure the absolute volume of 
the droplets dispensed by a SciFlexarrayer piezo nozzle. For each spot, a photograph of 
the droplet in midair is used to calculate the spotted volume. Based on the spot volume 
and concentration of the BSA solution, 25 pg to 400pg of BSA was spotted onto the 
surface. IRIS measurements were made on the sensor's surface after water evaporated 
leaving behind only the protein on the surface. 
Analvsis. The fabricated samples were imaged and processed usmg the IRIS 
platform. The processed images are analyzed by summing the pixels defining the spot 
and multiplying the area of analysis. Extracting the slope of the linear curve relating the 
spotted mass (ng) to the weighted sum of the IRIS thickness (nm*mm2) yields the scaling 
factor between Si02 thickness and biomass density. 
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Appendix B 
IRIS IN THE CLASSROOM 
High School Outreach. Passing knowledge to younger generations is one of the most 
critical and difficult aspects of science. Working alongside the Boston University 
Assistant Dean of Outreach and Diversity, educational activities centered around using 
discrete LEDs to illuminate a Si02 on Si chip with nanometer deep etched features has 
been developed. The goal of this activity is to teach students about thin-film interference. 
Low-cost IRIS detectors have been developed specifically for these outreach 
activities, Figure 5.7. By removing the translational stage, reducing the optics to a 
Nelsonian configuration, and implementing an eye-piece rather than a camera brought the 
cost below $800 per unit. These changes sacrificed the quantitative ability of the 
microscope, but observation is the goal of this project. The optical and mechanical parts 
used are off-the-shelf components and the LEDs are controlled with a custom electronic 
PCB for manually tuning the brightness. 
Laboratory Module: EC 481. The Fundamentals of Nanomaterials and 
Nanoteclmology aims to introduce undergraduate students to state-of-the-art optical and 
electronic techniques that deal with measuring or manipulating matter on the nanometer 
scale. To aid in the understanding of biological sensors and novel detection modalities, an 
IRIS laboratory module has been developed to introduce the concept of label-free 
detection. As shown in Figure 5.8, a stripped down version of the IRIS platform for 
classroom learning has been developed. 
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Sample Holder 
Figure 5.7: IRIS detector for demonstrating thin film interference at a low-cost 
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Sample Holder 
Figure 5.8: JRIS module for classrooms. This design implements a lower quality sensor and removes all 
moving parts to improve the ease-of-use, an important feature for instructional courses. 
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Appendix C 
IRIS PROTOTYPE 
Advancing the IRIS technology towards a simpler platform and faster computation 
collimated in the development of a standalone, easy-to-use prototype. A multidisciplinary 
senior design team ('12) was tasked with developing a standalone, automated IRIS 
instrument. A Kohler illumination configuration, a 2 in beamsplitter, and a standard 50 
mm macro lens attached to a camera are fixed on an aluminum plate for mechanical 
stability. As shown in Figure 5.9, the end result is a compact instrument (13 in x 7 in x 4 
in) with simple GUI and a large FOV (7.8 mm x 5.8 mm which corresponds to a 
maximum array of > 1000 assuming a 200 IJ.m spot pitch). Through the implementation of 
the graphics card processing algorithm and an automated spot detection algorithm, the 
acquisition and processing time has been decreased below 2 minutes on a laptop. With 
the development of a portable instrument capable of rapid measurements, the IRIS 
platform has reached a state where translation to commercial applications. 
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(a) (b) 
Figure 5.9: IRIS standalone prototype. (a) The prototype with the acrylic cover removed. Internally, the 
optics and electronics are seen. The slide sits on top facing down. (b) A screenshot of the custom software 
package for instrument control. This software requires few clicks for operation to initiate data acquisition 
and analysis. 
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Appendix D 
IRIS MODEL FITTING USING CUDA 
While the IRIS device has physically become more suitable for low-cost portable 
applications, the data processing necessary to compensate for the design changes tethers 
IRIS to a computing grid. In the spirit of moving towards a completely portable and field-
deployable system, the time required for data analysis must be addressed. 
Data fitting is the process in which the Levenberg-Marquardt algorithm is applied to 
the collected spectral data to minimize the sum-squared of errors (SSE) on a pixel-by-
pixel basis. Since the same algorithm must be applied to each pixel, the fitting of an 
image benefits from a single instruction, multiple data (SIMD) computing architecture. 
GPUs have been developed precisely for SIMD situations. Compared to a CPU, which is 
designed to be flexible and perform sequential operations, GPUs are specialized for 
simple parallel computation. Written by Dylan Jackson, Boston University M.S. '12, a 
CUDA implementation of the fitting process has shown remarkable performance gain, 
see Table 5.2. 
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Table 5.2: Performance ofiRIS/CaFE fitting algorithms on multiple hardware platforms 
Convergence Criteria 
(le-8)*SSE (le-6)*SSE (le-4)*SSE 
Hardware Type Model Type Average Processing Runtime 
GTX 680 (CC 3.0) IRIS 44.8 39.5 22.1 
GPU CaFE 4132.2 3193 .6 1875.1 
GTX 285 (CC 1.3) IRIS 206.7 174.0 93.4 
GPU CaFE *19070 0 *14068 *7941 
Grid ofi7-920 IRIS 525.9 332.2 308 
CPUs (Estimated) CaFE 16692 16525 14473 
i7-920 @ 2.67GHz IRIS 25765 15785 15132 
CPU (4cores, 8 threads) CaFE 832608 809725 709177 
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